Human	O
immunodeficiency	O
virus-associated	O
Hodgkin	O
's	O
disease	O
derives	O
from	O
post-germinal	B-cell_type
center	I-cell_type
B	I-cell_type
cells	I-cell_type
.	O

Human	O
immunodeficiency	O
virus-associated	O
Hodgkin	O
's	O
disease	O
(	O
HIV-HD	O
)	O
displays	O
several	O
peculiarities	O
when	O
compared	O
with	O
HD	O
of	O
the	O
general	O
population	O
.	O

These	O
include	O
overrepresentation	O
of	O
clinically	O
aggressive	O
histologic	O
types	O
and	O
frequent	O
infection	O
of	O
Reed-Sternberg	B-cell_line
(	I-cell_line
RS	I-cell_line
)	I-cell_line
cells	I-cell_line
by	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
.	O

Recently	O
,	O
we	O
have	O
reported	O
that	O
the	O
histogenesis	O
of	O
HD	O
of	O
the	O
general	O
population	O
may	O
be	O
assessed	O
by	O
monitoring	O
the	O
expression	O
pattern	O
of	O
BCL-6	B-protein
,	O
a	O
transcription	B-protein
factor	I-protein
expressed	O
in	O
germinal	B-cell_line
center	I-cell_line
(	I-cell_line
GC	I-cell_line
)	I-cell_line
B	I-cell_line
cells	I-cell_line
,	O
and	O
of	O
CD138/syndecan-1	B-protein
(	O
syn-1	B-protein
)	O
,	O
a	O
proteoglycan	O
associated	O
with	O
post-GC	O
,	O
terminal	O
B-cell	B-cell_type
differentiation	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
applied	O
these	O
two	O
markers	O
to	O
the	O
study	O
of	O
HIV-HD	O
histogenesis	O
and	O
correlated	O
their	O
expression	O
status	O
to	O
the	O
virologic	O
features	O
of	O
this	O
disease	O
.	O

We	O
have	O
found	O
that	O
RS	B-cell_line
cells	I-cell_line
of	O
all	O
histologic	O
categories	O
of	O
HIV-HD	O
consistently	O
display	O
the	O
BCL-6	B-protein
(	O
-	O
)	O
/syn-1	O
(	O
+	O
)	O
phenotype	O
and	O
thus	O
reflect	O
post-GC	B-cell_line
B	I-cell_line
cells	I-cell_line
.	O

Although	O
BCL-6	B-protein
(	O
-	O
)	O
/syn-1	O
(	O
+	O
)	O
RS	B-cell_line
cells	I-cell_line
of	O
HIV-HD	O
express	O
CD40	B-protein
,	O
they	O
are	O
not	O
surrounded	O
by	O
CD40	B-cell_type
ligand-positive	I-cell_type
(	I-cell_type
CD40L+	I-cell_type
)	I-cell_type
reactive	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
,	O
which	O
,	O
in	O
HD	O
of	O
the	O
general	O
population	O
,	O
are	O
thought	O
to	O
regulate	O
the	O
disease	O
phenotype	O
through	O
CD40	B-protein
/CD40L	B-protein
interactions	O
.	O

Conversely	O
,	O
RS	B-cell_line
cells	I-cell_line
of	O
virtually	O
all	O
HIV-HD	O
express	O
the	O
EBV-encoded	B-protein
latent	I-protein
membrane	I-protein
protein	I-protein
1	I-protein
(	O
LMP1	B-protein
)	O
,	O
which	O
,	O
being	O
functionally	O
homologous	O
to	O
CD40	B-protein
,	O
may	O
contribute	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
modulation	O
of	O
the	O
HIV-HD	O
phenotype	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NEOPLASIA	NULL
Human	NULL
Immunodeficiency	NULL
Virus-Associated	NULL
Hodgkin	NULL
's	NULL
Disease	NULL
Derives	NULL
From	NULL
Post-Germinal	NULL
Center	NULL
B	NULL
Cells	NULL
By	NULL
Antonino	NULL
Carbone	NULL
,	NULL
Annunziata	NULL
Gloghini	NULL
,	NULL
Luigi	NULL
M.	NULL
Larocca	NULL
,	NULL
Andrea	NULL
Antinori	NULL
,	NULL
Brunangelo	NULL
Falini	NULL
,	NULL
Umberto	NULL
Tirelli	NULL
,	NULL
Riccardo	NULL
Dalla-Favera	NULL
,	NULL
and	NULL
Gianluca	NULL
Gaidano	NULL
Human	NULL
immunodeficiency	NULL
virus-associated	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
HIV-HD	NULL
)	NULL
displays	NULL
several	NULL
peculiarities	NULL
when	NULL
compared	NULL
with	NULL
HD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
.	NULL

These	NULL
include	NULL
overrepre-sentation	NULL
of	NULL
clinically	NULL
aggressive	NULL
histologic	NULL
types	NULL
and	NULL
frequent	NULL
infection	NULL
of	NULL
Reed-Sternberg	NULL
(	NULL
RS	NULL
)	NULL
cells	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
histogenesis	NULL
of	NULL
HD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
may	NULL
be	NULL
assessed	NULL
by	NULL
monitoring	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
expressed	NULL
in	NULL
germinal	NULL
center	NULL
(	NULL
GC	NULL
)	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
of	NULL
CD138/	NULL
syndecan-1	NULL
(	NULL
syn-1	NULL
)	NULL
,	NULL
a	NULL
proteoglycan	NULL
associated	NULL
with	NULL
post-GC	NULL
,	NULL
terminal	NULL
B-cell	NULL
differentiation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
applied	NULL
these	NULL
two	NULL
markers	NULL
to	NULL
the	NULL
study	NULL
of	NULL
HIV-HD	NULL
histogenesis	NULL
and	NULL
correlated	NULL
their	NULL
expression	NULL
status	NULL
to	NULL
the	NULL
NDIVIDUALS	NULL
INFECTED	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
are	NULL
reported	NULL
to	NULL
be	NULL
at	NULL
increased	NULL
risk	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
HD	NULL
)	NULL
.	NULL

HIV-associated	NULL
HD	NULL
(	NULL
HIV-HD	NULL
)	NULL
displays	NULL
several	NULL
peculiarities	NULL
when	NULL
compared	NULL
with	NULL
HD	NULL
of	NULL
the	NULL
general	NULL
popula-tion	NULL
.	NULL

>	NULL
``	NULL
First	NULL
,	NULL
HIV-HD	NULL
exhibits	NULL
an	NULL
unusually	NULL
aggressive	NULL
clinical	NULL
behavior	NULL
,	NULL
which	NULL
mandates	NULL
the	NULL
use	NULL
of	NULL
specific	NULL
therapeutic	NULL
strategies	NULL
and	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
poor	NULL
prognosis	NULL
.	NULL
``	NULL

Second	NULL
,	NULL
the	NULL
pathologic	NULL
spectrum	NULL
of	NULL
HIV-HD	NULL
differs	NULL
markedly	NULL
from	NULL
that	NULL
of	NULL
HD	NULL
in	NULL
the	NULL
general	NULL
population	NULL
.	NULL

``	NULL
**	NULL
In	NULL
particular	NULL
,	NULL
the	NULL
aggressive	NULL
histologic	NULL
subtypes	NULL
of	NULL
classic	NULL
HD	NULL
(	NULL
CHD	NULL
)	NULL
,	NULL
namely	NULL
mixed	NULL
cellularity	NULL
(	NULL
MC	NULL
)	NULL
and	NULL
lymphocyte	NULL
depletion	NULL
(	NULL
LD	NULL
)	NULL
,	NULL
predominate	NULL
among	NULL
HIV-HD	NULL
and	NULL
the	NULL
tumor	NULL
tissue	NULL
is	NULL
characterized	NULL
by	NULL
an	NULL
unusually	NULL
large	NULL
proportion	NULL
of	NULL
neoplastic	NULL
cells	NULL
,	NULL
termed	NULL
Reed-Sternberg	NULL
(	NULL
RS	NULL
)	NULL
cells.8	NULL
The	NULL
biologic	NULL
reasons	NULL
for	NULL
the	NULL
clinicopathologic	NULL
peculiarities	NULL
of	NULL
HIV-HD	NULL
are	NULL
known	NULL
only	NULL
in	NULL
part	NULL
and	NULL
may	NULL
reflect	NULL
peculiarities	NULL
in	NULL
the	NULL
tumor	NULL
microenvironment	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
tumor	NULL
clone	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
on	NULL
the	NULL
one	NULL
hand	NULL
,	NULL
the	NULL
HIV-HD	NULL
microenvironment	NULL
is	NULL
characterized	NULL
by	NULL
inversion	NULL
of	NULL
the	NULL
CD4*/CD8*	NULL
T-cell	NULL
ratio	NULL
,	NULL
whereas	NULL
CD4*	NULL
T	NULL
cells	NULL
predominate	NULL
in	NULL
the	NULL
microenvironment	NULL
of	NULL
CHD	NULL
in	NULL
the	NULL
general	NULL
population	NULL
.	NULL
``	NULL

''	NULL
On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
overwhelming	NULL
majority	NULL
of	NULL
HIV-HD	NULL
is	NULL
associated	NULL
with	NULL
RS	NULL
cell	NULL
infection	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
,	NULL
which	NULL
is	NULL
restricted	NULL
to	NULL
a	NULL
fraction	NULL
of	NULL
CHD	NULL
in	NULL
the	NULL
general	NULL
population	NULL
.	NULL
``	NULL

''	NULL
Because	NULL
RS	NULL
cells	NULL
of	NULL
EBV-positive	NULL
HIV-HD	NULL
express	NULL
the	NULL
virus-encoded	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
,	NULL
EBV	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

During	NULL
the	NULL
last	NULL
few	NULL
years	NULL
,	NULL
molecular	NULL
investigations	NULL
have	NULL
documented	NULL
that	NULL
RS	NULL
cells	NULL
of	NULL
most	NULL
HD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
derive	NULL
from	NULL
germinal	NULL
center	NULL
(	NULL
GC	NULL
)	NULL
-related	NULL
B	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
stimulated	NULL
and	NULL
selected	NULL
by	NULL
Recently	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
precise	NULL
differentiation	NULL
stage	NULL
of	NULL
RS	NULL
cells	NULL
can	NULL
be	NULL
reliably	NULL
identified	NULL
based	NULL
on	NULL
the	NULL
expression	NULL
profile	NULL
of	NULL
BCL-6	NULL
and	NULL
CD138/syndecan-1	NULL
(	NULL
syn-1	NULL
)	NULL
.	NULL
'	NULL

''	NULL
The	NULL
BCL-6	NULL
protein	NULL
is	NULL
a	NULL
zinc-finger	NULL
transcriptional	NULL
repressor	NULL
encoded	NULL
by	NULL
the	NULL
BCL-6	NULL
proto-oncogene	NULL
and	NULL
is	NULL
implicated	NULL
in	NULL
normal	NULL
GC	NULL
formation	NULL
and	NULL
function	NULL
.	NULL

'*	NULL
``	NULL
In	NULL
the	NULL
B-cell	NULL
compartment	NULL
,	NULL
BCL-6	NULL
expression	NULL
clusters	NULL
with	NULL
GC	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
negative	NULL
in	NULL
all	NULL
other	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
,	NULL
including	NULL
virgin	NULL
and	NULL
memory	NULL
B	NULL
cells	NULL
and	NULL
plasma	NULL
cells	NULL
.	NULL
``	NULL

Expression	NULL
of	NULL
BCL-6	NULL
in	NULL
GC	NULL
B	NULL
cells	NULL
is	NULL
Blood	NULL
,	NULL
Vol	NULL
93	NULL
,	NULL
No	NULL
7	NULL
(	NULL
April	NULL
1	NULL
)	NULL
,	NULL
1999	NULL
;	NULL
pp	NULL
2319-2326	NULL
virologic	NULL
features	NULL
of	NULL
this	NULL
disease	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
RS	NULL
cells	NULL
of	NULL
all	NULL
histologic	NULL
categories	NULL
of	NULL
HIV-HD	NULL
consistently	NULL
display	NULL
the	NULL
BCL-6-/syn-1*	NULL
phenotype	NULL
and	NULL
thus	NULL
reflect	NULL
post-GC	NULL
B	NULL
cells	NULL
.	NULL

Although	NULL
BCL-6-/	NULL
syn-1+*	NULL
RS	NULL
cells	NULL
of	NULL
HIV-HD	NULL
express	NULL
CD40	NULL
,	NULL
they	NULL
are	NULL
not	NULL
surrounded	NULL
by	NULL
CD40	NULL
ligand	NULL
,	NULL
positive	NULL
(	NULL
CD40L+	NULL
)	NULL
reactive	NULL
T	NULL
lymphocytes	NULL
,	NULL
which	NULL
,	NULL
in	NULL
HD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
,	NULL
are	NULL
thought	NULL
to	NULL
regulate	NULL
the	NULL
disease	NULL
phenotype	NULL
through	NULL
CD40/CD4O0L	NULL
interactions	NULL
.	NULL

Conversely	NULL
,	NULL
RS	NULL
cells	NULL
of	NULL
virtually	NULL
all	NULL
HIV-HD	NULL
express	NULL
the	NULL
EBV-encoded	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LM	NULL
P1	NULL
)	NULL
,	NULL
which	NULL
,	NULL
being	NULL
functionally	NULL
homologous	NULL
to	NULL
CD40	NULL
,	NULL
may	NULL
contribute	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
to	NULL
the	NULL
modulation	NULL
of	NULL
the	NULL
HIV-HD	NULL
phenotype	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

downregulated	NULL
upon	NULL
challenge	NULL
with	NULL
antigen	NULL
or	NULL
via	NULL
the	NULL
CD40/	NULL
CD40	NULL
ligand	NULL
(	NULL
CD4O0L	NULL
)	NULL
pathway	NULL
.	NULL
``	NULL

Similarly	NULL
,	NULL
downregulation	NULL
of	NULL
BCL-6	NULL
is	NULL
caused	NULL
by	NULL
expression	NULL
of	NULL
LMP	NULL
1	NULL
in	NULL
B	NULL
cells	NULL
reflecting	NULL
the	NULL
GC	NULL
phenotype	NULL
.	NULL
``	NULL

Syn-1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
syndecan	NULL
family	NULL
of	NULL
proteoglycans	NULL
,	NULL
which	NULL
are	NULL
implicated	NULL
in	NULL
cell-extracellular	NULL
matrix	NULL
interactions	NULL
.	NULL
``	NULL

Among	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
expression	NULL
of	NULL
syn-1	NULL
clusters	NULL
with	NULL
late	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
,	NULL
namely	NULL
immunoblasts	NULL
and	NULL
plasma	NULL
cells	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
negative	NULL
in	NULL
GC	NULL
B	NULL
cells.2124	NULL
Here	NULL
,	NULL
we	NULL
aimed	NULL
to	NULL
define	NULL
the	NULL
histogenesis	NULL
of	NULL
HIV-HD	NULL
.	NULL

We	NULL
report	NULL
that	NULL
RS	NULL
cells	NULL
of	NULL
HIV-HD	NULL
consistently	NULL
express	NULL
the	NULL
BCL-6~/syn-1	NULL
*	NULL
profile	NULL
and	NULL
thus	NULL
reflect	NULL
post-GC	NULL
B	NULL
cells	NULL
.	NULL

CD40+	NULL
RS	NULL
cells	NULL
of	NULL
HIV-HD	NULL
are	NULL
not	NULL
surrounded	NULL
by	NULL
CD4OL+*	NULL
T	NULL
lymphocytes	NULL
,	NULL
which	NULL
are	NULL
conversely	NULL
abundant	NULL
in	NULL
CHD	NULL
of	NULL
the	NULL
From	NULL
the	NULL
Divisions	NULL
of	NULL
Pathology	NULL
and	NULL
Medical	NULL
Oncology	NULL
and	NULL
the	NULL
AIDS	NULL
Program	NULL
,	NULL
Centro	NULL
di	NULL
Riferimento	NULL
Oncologico	NULL
,	NULL
Istituto	NULL
Nazionale	NULL
Tumori	NULL
,	NULL
Istituto	NULL
di	NULL
Ricovero	NULL
e	NULL
Cura	NULL
a	NULL
Carattere	NULL
Scientifico	NULL
(	NULL
IRCCS	NULL
)	NULL
,	NULL
Aviano	NULL
;	NULL
Institutes	NULL
of	NULL
Pathology	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Universita	NULL
Cattolica	NULL
del	NULL
Sacro	NULL
Cuore	NULL
,	NULL
Roma	NULL
;	NULL
Institute	NULL
of	NULL
Hematology	NULL
,	NULL
University	NULL
of	NULL
Perugia	NULL
,	NULL
Perugia	NULL
;	NULL
the	NULL
Division	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Medical	NULL
Sciences	NULL
,	NULL
Amedeo	NULL
Avogadro	NULL
University	NULL
of	NULL
Eastern	NULL
Piedmont	NULL
,	NULL
Novara	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Oncology	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
.	NULL

Submitted	NULL
August	NULL
7	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
November	NULL
17	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
(	NULL
ISS	NULL
)	NULL
,	NULL
Pro-gramma	NULL
nazionale	NULL
di	NULL
ricerca	NULL
sull'AIDS	NULL
1997-Progeitto	NULL
Patologia	NULL
clinica	NULL
e	NULL
terapia	NULL
dell	NULL
AIDS	NULL
(	NULL
304.0.10	NULL
,	NULL
30A.0.62	NULL
,	NULL
and	NULL
30A.0.67	NULL
)	NULL
,	NULL
Rome	NULL
;	NULL
Associazione	NULL
Italiana	NULL
per	NULL
la	NULL
Ricerca	NULL
sul	NULL
Cancro	NULL
,	NULL
Milan	NULL
;	NULL
Fondazione	NULL
CRT	NULL
,	NULL
Torino	NULL
;	NULL
Fondazione	NULL
Piera	NULL
,	NULL
Pietro	NULL
e	NULL
Giovanni	NULL
Ferrero	NULL
,	NULL
Alba	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
No	NULL
.	NULL

CA-37295	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Antonino	NULL
Carbone	NULL
,	NULL
MD	NULL
,	NULL
Division	NULL
of	NULL
Pathology	NULL
,	NULL
Centro	NULL
di	NULL
Riferimento	NULL
Oncologico	NULL
,	NULL
Istituto	NULL
Nazionale	NULL
Tumori	NULL
,	NULL
IRCCS	NULL
,	NULL
via	NULL
Pedemontana	NULL
Occidentale	NULL
,	NULL
Aviano	NULL
1-33081	NULL
,	NULL
Italy	NULL
;	NULL
e-mail	NULL
:	NULL
acarbone	NULL
@	NULL
ets.it	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/99/9307-0004	NULL
$	NULL
3.00/0	NULL
2319	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2320	NULL
general	NULL
population	NULL
.	NULL
``	NULL

''	NULL
RS	NULL
cells	NULL
of	NULL
HIV-HD	NULL
consistently	NULL
express	NULL
LMP1	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
modulation	NULL
of	NULL
the	NULL
RS	NULL
cell	NULL
phenotype	NULL
in	NULL
this	NULL
context	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Samples	NULL
This	NULL
study	NULL
was	NULL
based	NULL
on	NULL
27	NULL
lymph	NULL
node	NULL
samples	NULL
involved	NULL
in	NULL
HD	NULL
from	NULL
patients	NULL
with	NULL
HIV	NULL
infection	NULL
.	NULL

All	NULL
cases	NULL
were	NULL
histologically	NULL
classified	NULL
as	NULL
CHD	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
panel	NULL
included	NULL
7	NULL
HD	NULL
with	NULL
B-cell	NULL
phenotype	NULL
(	NULL
3	NULL
MC	NULL
and	NULL
four	NULL
LD	NULL
)	NULL
and	NULL
20	NULL
HD	NULL
with	NULL
undetermined	NULL
(	NULL
non-B/non-T-cell	NULL
)	NULL
phenotype	NULL
(	NULL
2	NULL
nodular	NULL
sclerosis	NULL
[	NULL
NS	NULL
]	NULL
,	NULL
13	NULL
MC	NULL
,	NULL
and	NULL
5	NULL
LD	NULL
)	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

No	NULL
cases	NULL
of	NULL
HIV-HD	NULL
with	NULL
a	NULL
T-cell	NULL
phenotype	NULL
were	NULL
studied	NULL
.	NULL

Frozen	NULL
tissue	NULL
samples	NULL
were	NULL
available	NULL
in	NULL
12	NULL
cases	NULL
;	NULL
for	NULL
the	NULL
other	NULL
samples	NULL
,	NULL
formalin-	NULL
or	NULL
Bouin-fixed	NULL
,	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
were	NULL
available	NULL
.	NULL

The	NULL
CD30+	NULL
,	NULL
CD45~	NULL
,	NULL
CD15*	NULL
,	NULL
epithelial	NULL
membrane	NULL
antigen	NULL
(	NULL
EMA	NULL
)	NULL
~	NULL
diagnostic	NULL
profile	NULL
was	NULL
required	NULL
for	NULL
the	NULL
diagnosis	NULL
of	NULL
HD	NULL
.	NULL
``	NULL

The	NULL
Rye	NULL
modification	NULL
of	NULL
the	NULL
Lukes	NULL
and	NULL
Butler	NULL
classification	NULL
was	NULL
used	NULL
to	NULL
classify	NULL
the	NULL
histologic	NULL
subtypes	NULL
of	NULL
HD	NULL
.	NULL
``	NULL

Distinct	NULL
nodule	NULL
and	NULL
collagen-band	NULL
formation	NULL
was	NULL
required	NULL
to	NULL
diagnose	NULL
the	NULL
NS	NULL
subtype	NULL
,	NULL
whereas	NULL
lymph	NULL
node	NULL
biopsies	NULL
characterized	NULL
by	NULL
increased	NULL
fibrohistiocytoid	NULL
stromal	NULL
cells	NULL
Table	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
CD40	NULL
,	NULL
CD138/	NULL
syn-1	NULL
,	NULL
BCL-6	NULL
,	NULL
and	NULL
LMP1	NULL
by	NULL
RS	NULL
Cells	NULL
of	NULL
HIV-HD	NULL
Case	NULL
HD	NULL
CD40	NULL
_	NULL
syn-1	NULL
_	NULL
BCL-6	NULL
-	NULL
LMP1	NULL
No	NULL
.	NULL

Subtype	NULL
-	NULL
Phenotype	NULL
(	NULL
%	NULL
)	NULL
*	NULL
(	NULL
%	NULL
)	NULL
``	NULL
(	NULL
%	NULL
)	NULL
``	NULL
(	NULL
%	NULL
)	NULL
*	NULL
EBV	NULL
?	NULL

1	NULL
MC	NULL
B	NULL
>	NULL
75	NULL
>	NULL
75	NULL
0	NULL
-	NULL
25-50	NULL
+	NULL
2	NULL
MCt	NULL
B	NULL
>	NULL
75	NULL
>	NULL
75	NULL
0	NULL
>	NULL
75	NULL
+	NULL
3	NULL
MCt	NULL
B	NULL
>	NULL
75	NULL
-	NULL
25-50	NULL
0	NULL
-	NULL
50-75	NULL
+	NULL
4	NULL
MC	NULL
UD	NULL
>	NULL
75	NULL
-	NULL
25-50	NULL
0	NULL
-	NULL
25-50	NULL
+	NULL
5	NULL
MC	NULL
UD	NULL
>	NULL
75	NULL
10-25	NULL
0	NULL
0	NULL
6	NULL
MC§	NULL
UD	NULL
>	NULL
75	NULL
50-750	NULL
<	NULL
10	NULL
>	NULL
75	NULL
+	NULL
7	NULL
MC	NULL
UD	NULL
>	NULL
75	NULL
<	NULL
10	NULL
0	NULL
_	NULL
<	NULL
10	NULL
+	NULL
8	NULL
MCt	NULL
UD	NULL
>	NULL
75	NULL
-	NULL
50-75	NULL
0	NULL
-	NULL
50-75	NULL
+	NULL
9	NULL
MC	NULL
UD	NULL
50-75	NULL
-	NULL
<	NULL
10	NULL
0	NULL
<	NULL
10	NULL
+	NULL
10	NULL
MC	NULL
UD	NULL
>	NULL
75	NULL
>	NULL
75	NULL
0	NULL
-	NULL
50-75	NULL
+	NULL
11	NULL
MC	NULL
UD	NULL
>	NULL
75	NULL
-	NULL
25-50	NULL
0	NULL
-	NULL
25-50	NULL
+	NULL
12	NULL
MC	NULL
UD	NULL
50-75	NULL
50-75	NULL
0	NULL
<	NULL
10	NULL
+	NULL
13	NULL
MCt	NULL
UD	NULL
50-75	NULL
10-25	NULL
0	NULL
-	NULL
10-25	NULL
+	NULL
14	NULL
MC	NULL
UD	NULL
>	NULL
75	NULL
50-75	NULL
<	NULL
10	NULL
10-25	NULL
+	NULL
15	NULL
MC§	NULL
UD	NULL
>	NULL
75	NULL
10-25	NULL
0	NULL
-	NULL
50-75	NULL
+	NULL
16	NULL
MC	NULL
UD	NULL
50-75	NULL
-	NULL
>	NULL
75	NULL
0	NULL
<	NULL
10	NULL
+	NULL
17	NULL
LD	NULL
B	NULL
>	NULL
75	NULL
<	NULL
10	NULL
0	NULL
-	NULL
50-75	NULL
+	NULL
18	NULL
LD	NULL
B	NULL
>	NULL
75	NULL
-	NULL
25-50	NULL
0	NULL
>	NULL
75	NULL
+	NULL
19	NULL
LD	NULL
B	NULL
>	NULL
75	NULL
-	NULL
50-75	NULL
0	NULL
>	NULL
75	NULL
+	NULL
20	NULL
LD	NULL
B	NULL
>	NULL
75	NULL
>	NULL
75	NULL
0	NULL
0	NULL
21	NULL
LD	NULL
UD	NULL
50-75	NULL
-	NULL
<	NULL
10	NULL
0	NULL
>	NULL
75	NULL
+	NULL
22	NULL
LD	NULL
UD	NULL
50-75	NULL
-	NULL
<	NULL
10	NULL
0	NULL
>	NULL
75	NULL
+	NULL
23	NULL
LD	NULL
UD	NULL
50-75	NULL
-	NULL
<	NULL
10	NULL
0	NULL
<	NULL
10	NULL
+	NULL
24	NULL
LD	NULL
UD	NULL
50-75	NULL
-	NULL
25-50	NULL
0	NULL
>	NULL
75	NULL
+	NULL
25	NULL
LD	NULL
UD	NULL
>	NULL
75	NULL
>	NULL
75	NULL
0	NULL
>	NULL
75	NULL
+	NULL
26	NULL
NS	NULL
UD	NULL
>	NULL
75	NULL
>	NULL
75	NULL
0	NULL
<	NULL
10	NULL
]	NULL
+	NULL
27	NULL
NS	NULL
UD	NULL
>	NULL
75	NULL
<	NULL
10	NULL
0	NULL
<	NULL
10	NULL
+	NULL
Abbreviations	NULL
:	NULL
UD	NULL
,	NULL
undetermined	NULL
{	NULL
non-B/non-T-cell	NULL
phenotype	NULL
)	NULL
;	NULL
B	NULL
,	NULL
B-cell	NULL
phenotype	NULL
.	NULL

*The	NULL
percentage	NULL
of	NULL
CD40+	NULL
,	NULL
syn-1+	NULL
,	NULL
BCL-6+	NULL
,	NULL
and	NULL
LMP1+*	NULL
neoplastic	NULL
cells	NULL
was	NULL
assigned	NULL
to	NULL
1	NULL
of	NULL
the	NULL
following	NULL
categories	NULL
:	NULL
0	NULL
%	NULL
,	NULL
<	NULL
10	NULL
%	NULL
,	NULL
10	NULL
%	NULL
-25	NULL
%	NULL
,	NULL
25	NULL
%	NULL
-50	NULL
%	NULL
,	NULL
50	NULL
%	NULL
-75	NULL
%	NULL
,	NULL
and	NULL
>	NULL
75	NULL
%	NULL
.	NULL

{	NULL
EBV	NULL
status	NULL
as	NULL
assessed	NULL
by	NULL
EBER	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

{	NULL
Fibrohistiocytoid	NULL
stromal	NULL
cells	NULL
in	NULL
the	NULL
background	NULL
.	NULL

§Epithelioid	NULL
histiocytes	NULL
in	NULL
the	NULL
background	NULL
.	NULL

|Occasional	NULL
positivity	NULL
.	NULL

CARBONE	NULL
ET	NULL
AL	NULL
arranged	NULL
in	NULL
bundles	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
were	NULL
classified	NULL
as	NULL
the	NULL
MC	NULL
subtype	NULL
.	NULL

*	NULL
Tumors	NULL
were	NULL
classified	NULL
as	NULL
the	NULL
LD	NULL
subtype	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
diagnostic	NULL
features	NULL
for	NULL
either	NULL
the	NULL
``	NULL
diffuse	NULL
fibrosis	NULL
``	NULL
or	NULL
``	NULL
reticular	NULL
``	NULL
subtype	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
Immunohistochemistry	NULL
Immunohistochemistry	NULL
(	NULL
IHC	NULL
)	NULL
was	NULL
performed	NULL
on	NULL
frozen-section	NULL
and	NULL
on	NULL
Bouin-	NULL
or	NULL
Formalin-fixed	NULL
,	NULL
paraffin-embedded	NULL
tissues	NULL
.	NULL

The	NULL
protocol	NULL
used	NULL
for	NULL
each	NULL
antigen	NULL
tested	NULL
is	NULL
described	NULL
.	NULL

Control	NULL
experiments	NULL
,	NULL
which	NULL
were	NULL
invariably	NULL
negative	NULL
,	NULL
consisted	NULL
of	NULL
omission	NULL
of	NULL
the	NULL
primary	NULL
antibody	NULL
,	NULL
substitution	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
or	NULL
staining	NULL
with	NULL
irrelevant	NULL
isotype-matched	NULL
mouse	NULL
Ig	NULL
.	NULL

Syn-1	NULL
antigen	NULL
.	NULL

-	NULL
The	NULL
anti-B-B4	NULL
monoclonal	NULL
antibody	NULL
(	NULL
[	NULL
MoAb	NULL
]	NULL
Sero-tec	NULL
,	NULL
Oxford	NULL
,	NULL
England	NULL
)	NULL
,	NULL
which	NULL
specifically	NULL
recognizes	NULL
the	NULL
syn-1	NULL
anti-gen	NULL
,	NULL
``	NULL
*	NULL
was	NULL
applied	NULL
to	NULL
frozen	NULL
or	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
.	NULL

IHC	NULL
for	NULL
syn-1	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
monoclonal	NULL
antialkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
)	NULL
method	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

BCL-6	NULL
protein	NULL
.	NULL

The	NULL
BCL-6	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
the	NULL
PG-B6	NULL
MoAb	NULL
.	NULL

``	NULL
°	NULL
Immunostaining	NULL
for	NULL
BCL-6	NULL
was	NULL
performed	NULL
on	NULL
frozen	NULL
or	NULL
Formalin-fixed	NULL
,	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
by	NULL
the	NULL
APAAP	NULL
method	NULL
.	NULL
``	NULL

''	NULL
Paraffin-embedded	NULL
tissue	NULL
sections	NULL
were	NULL
pretreated	NULL
in	NULL
a	NULL
microwave	NULL
oven	NULL
(	NULL
Jet	NULL
900	NULL
W	NULL
;	NULL
Philips	NULL
Eindhaven	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
250	NULL
W	NULL
in	NULL
EDTA	NULL
solution	NULL
(	NULL
0.05	NULL
mmol	NULL
,	NULL
pH	NULL
8	NULL
)	NULL
.	NULL

CD40	NULL
and	NULL
CD4OL	NULL
.	NULL

-	NULL
Anti-CD40	NULL
MoAb	NULL
89	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
J.	NULL
Bancherau	NULL
,	NULL
Centre	NULL
de	NULL
Recherche	NULL
,	NULL
Schering-Plough	NULL
,	NULL
Dardilly	NULL
,	NULL
France	NULL
)	NULL
was	NULL
applied	NULL
to	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
from	NULL
all	NULL
HD	NULL
cases	NULL
.	NULL

Anti-CD40L	NULL
MoAb	NULL
M90	NULL
(	NULL
Genzyme	NULL
Diagnostic	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
was	NULL
applied	NULL
only	NULL
to	NULL
frozen	NULL
sections	NULL
because	NULL
of	NULL
its	NULL
lack	NULL
of	NULL
reactivity	NULL
in	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
.	NULL

IHC	NULL
for	NULL
CD40	NULL
and	NULL
CD4O0L	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
APAAP	NULL
method	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
'	NULL

''	NULL
``	NULL
``	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
.	NULL

Antibodies	NULL
recognizing	NULL
CD3	NULL
(	NULL
clone	NULL
SK7	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
CD4	NULL
(	NULL
clone	NULL
SK3	NULL
;	NULL
Becton	NULL
Dickinson	NULL
)	NULL
,	NULL
and	NULL
CD8	NULL
(	NULL
clone	NULL
SK1	NULL
;	NULL
Becton	NULL
Dickinson	NULL
)	NULL
were	NULL
applied	NULL
to	NULL
frozen	NULL
sections	NULL
and	NULL
immunostained	NULL
by	NULL
the	NULL
APAAP	NULL
method	NULL
.	NULL
``	NULL

Antibodies	NULL
recognizing	NULL
CD3	NULL
(	NULL
polyclonal	NULL
antibody	NULL
;	NULL
Dako	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
;	NULL
or	NULL
clone	NULL
PS1	NULL
;	NULL
Immunotech	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
,	NULL
CD4	NULL
(	NULL
clone	NULL
1F6	NULL
;	NULL
Novocas-tra	NULL
Laboratories	NULL
,	NULL
Newcastle	NULL
upon	NULL
Tyne	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
or	NULL
CD8	NULL
(	NULL
clone	NULL
C8/144B	NULL
;	NULL
Dako	NULL
)	NULL
were	NULL
applied	NULL
to	NULL
paraffin-embedded	NULL
tissues	NULL
.	NULL

Sections	NULL
were	NULL
pretreated	NULL
in	NULL
a	NULL
microwave	NULL
oven	NULL
twice	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
650	NULL
W	NULL
in	NULL
citrate	NULL
buffer	NULL
pH	NULL
6	NULL
(	NULL
for	NULL
CD3	NULL
and	NULL
CD8	NULL
)	NULL
or	NULL
three	NULL
times	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
700	NULL
W	NULL
in	NULL
EGTA	NULL
1	NULL
mmol/L	NULL
,	NULL
pH	NULL
8	NULL
(	NULL
for	NULL
CD4	NULL
)	NULL
.	NULL

IHC	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
ABC	NULL
method	NULL
(	NULL
ABC-Elite	NULL
kit	NULL
;	NULL
Vector	NULL
,	NULL
Burlingame	NULL
,	NULL
CA	NULL
)	NULL
.	NULL
``	NULL

A	NULL
reliable	NULL
immuno-stain	NULL
for	NULL
CD4	NULL
could	NULL
be	NULL
obtained	NULL
only	NULL
in	NULL
freshly	NULL
cut	NULL
tissue	NULL
sections	NULL
.	NULL

Lineage	NULL
assignment	NULL
.	NULL

|	NULL
Further	NULL
immunophenotyping	NULL
and	NULL
lineage	NULL
assignment	NULL
of	NULL
RS	NULL
cells	NULL
was	NULL
performed	NULL
with	NULL
antibodies	NULL
against	NULL
conventional	NULL
B-	NULL
and	NULL
T-cell-associated	NULL
antigens	NULL
,	NULL
as	NULL
reported	NULL
in	NULL
detail	NULL
previ-ously.3233	NULL
Assessment	NULL
of	NULL
CD40	NULL
,	NULL
syn-1	NULL
,	NULL
and	NULL
BCL-6	NULL
Staining	NULL
in	NULL
RS	NULL
Cells	NULL
of	NULL
HD	NULL
Samples	NULL
At	NULL
least	NULL
100	NULL
neoplastic	NULL
cells	NULL
per	NULL
section	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
histologic	NULL
and	NULL
immunohistologic	NULL
criteria	NULL
(	NULL
CD30	NULL
positivity	NULL
)	NULL
,	NULL
were	NULL
independently	NULL
counted	NULL
by	NULL
two	NULL
members	NULL
of	NULL
our	NULL
group	NULL
(	NULL
A.C.	NULL
and	NULL
A.G.	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
CD40*	NULL
,	NULL
syn-1*	NULL
,	NULL
or	NULL
BCL-6*	NULL
neoplastic	NULL
cells	NULL
was	NULL
assigned	NULL
as	NULL
follows	NULL
:	NULL
0	NULL
%	NULL
,	NULL
less	NULL
than	NULL
10	NULL
%	NULL
,	NULL
10	NULL
%	NULL
to	NULL
25	NULL
%	NULL
,	NULL
25	NULL
%	NULL
to	NULL
50	NULL
%	NULL
,	NULL
50	NULL
%	NULL
to	NULL
75	NULL
%	NULL
,	NULL
and	NULL
greater	NULL
than	NULL
75	NULL
%	NULL
.	NULL

Only	NULL
definite	NULL
and	NULL
unambiguous	NULL
staining	NULL
on	NULL
unequivocally	NULL
malignant	NULL
cells	NULL
was	NULL
scored	NULL
as	NULL
positive	NULL
.	NULL

Assessment	NULL
of	NULL
CD40L*	NULL
,	NULL
CD3	NULL
#	NULL
,	NULL
CD4*	NULL
,	NULL
and	NULL
CD8+	NULL
T	NULL
Lymphocytes	NULL
in	NULL
the	NULL
Reactive	NULL
Background	NULL
of	NULL
HD	NULL
HIV-HD	NULL
cases	NULL
were	NULL
also	NULL
studied	NULL
for	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
reactive	NULL
background	NULL
by	NULL
comparing	NULL
serial	NULL
frozen	NULL
sections	NULL
immunostained	NULL
with	NULL
CD40L	NULL
,	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
.	NULL

Paraffin-embedded	NULL
sections	NULL
were	NULL
immunostained	NULL
with	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
in	NULL
cases	NULL
for	NULL
which	NULL
frozen	NULL
sections	NULL
were	NULL
not	NULL
available	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HISTOGENESIS	NULL
OF	NULL
HIV+	NULL
HODGKIN	NULL
'S	NULL
DISEASE	NULL
Assessment	NULL
of	NULL
CD40L	NULL
*	NULL
,	NULL
CD3	NULL
#	NULL
+	NULL
,	NULL
CD4*	NULL
,	NULL
and	NULL
CD8~*	NULL
T	NULL
lymphocytes	NULL
in	NULL
the	NULL
reactive	NULL
background	NULL
of	NULL
HD	NULL
was	NULL
independently	NULL
performed	NULL
by	NULL
two	NULL
of	NULL
us	NULL
(	NULL
A.G.	NULL
and	NULL
L.M.L	NULL
.	NULL
)	NULL

.	NULL

In	NULL
serial	NULL
tissue	NULL
sections	NULL
from	NULL
each	NULL
case	NULL
,	NULL
the	NULL
same	NULL
areas	NULL
were	NULL
evaluated	NULL
for	NULL
lymphocytes	NULL
expressing	NULL
CD3	NULL
,	NULL
CD4O0L	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10	NULL
fields	NULL
were	NULL
evaluated	NULL
(	NULL
magnification	NULL
X63	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
lymphocytes	NULL
expressing	NULL
CD4OL	NULL
was	NULL
counted	NULL
on	NULL
the	NULL
total	NULL
of	NULL
CD3+*	NULL
T	NULL
cells	NULL
.	NULL

Five	NULL
lymph	NULL
node	NULL
samples	NULL
involved	NULL
in	NULL
CHD	NULL
from	NULL
patients	NULL
without	NULL
HIV	NULL
infection	NULL
were	NULL
also	NULL
studied	NULL
for	NULL
control	NULL
purposes	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Two-Color	NULL
Staining	NULL
Multiple	NULL
immunocytochemical	NULL
staining	NULL
was	NULL
performed	NULL
to	NULL
detect	NULL
BCL-6	NULL
plus	NULL
LMP1	NULL
or	NULL
BCL-6	NULL
plus	NULL
syn-1	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
sections	NULL
were	NULL
first	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
with	NULL
BCL-6	NULL
MoAb	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
immunostained	NULL
by	NULL
the	NULL
APAAP	NULL
method	NULL
``	NULL
``	NULL
using	NULL
naphthol	NULL
AS-MX	NULL
phosphate	NULL
along	NULL
with	NULL
fast	NULL
blue	NULL
BB	NULL
salt	NULL
(	NULL
Sigma	NULL
Chemical	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
for	NULL
the	NULL
development	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
.	NULL

Subsequently	NULL
,	NULL
sections	NULL
were	NULL
treated	NULL
twice	NULL
for	NULL
5	NULL
minutes	NULL
in	NULL
citrate	NULL
buffer	NULL
(	NULL
pH	NULL
6	NULL
)	NULL
in	NULL
a	NULL
microwave	NULL
oven	NULL
to	NULL
denature	NULL
bound	NULL
antibody	NULL
molecules	NULL
and	NULL
to	NULL
inactivate	NULL
alkaline	NULL
phosphatase	NULL
present	NULL
in	NULL
the	NULL
APAAP	NULL
complex	NULL
.	NULL

Finally	NULL
,	NULL
sections	NULL
were	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
anti-LMP1	NULL
or	NULL
anti-syn-1	NULL
MoAb	NULL
and	NULL
immunostained	NULL
by	NULL
the	NULL
APAAP	NULL
method	NULL
using	NULL
Table	NULL
2	NULL
.	NULL

CD4+/CD8+	NULL
Cell	NULL
Ratio	NULL
and	NULL
CD40L+	NULL
T	NULL
Lymphocytes	NULL
in	NULL
the	NULL
Reactive	NULL
Background	NULL
of	NULL
HIV-HD	NULL
as	NULL
Assessed	NULL
by	NULL
IHC	NULL
Case	NULL
No	NULL
.	NULL

HD	NULL
Subtype	NULL
CD4*/CD8+	NULL
Cell	NULL
Ratio	NULL
CDA40Lf	NULL
(	NULL
%	NULL
)	NULL
*t	NULL
1	NULL
MC	NULL
0.28	NULL
3.42	NULL
2	NULL
MC	NULL
0.12	NULL
0.26	NULL
3	NULL
MC	NULL
1.12	NULL
4	NULL
MC	NULL
0.4	NULL
6.97	NULL
5	NULL
MC	NULL
1.47	NULL
7.3	NULL
6	NULL
MC	NULL
1.41	NULL
7.97	NULL
7	NULL
MC	NULL
0.26	NULL
2.8	NULL
8	NULL
MC	NULL
0.05	NULL
9	NULL
MC	NULL
0.97	NULL
3.46	NULL
10	NULL
MC	NULL
0.28	NULL
1.16	NULL
11	NULL
MC	NULL
0.12	NULL
12	NULL
MC	NULL
0.5	NULL
13	NULL
MC	NULL
0.05	NULL
14	NULL
MC	NULL
0.7	NULL
15	NULL
MC	NULL
0.2	NULL
16	NULL
MC	NULL
0.15	NULL
17	NULL
LD	NULL
0.16	NULL
18	NULL
LD	NULL
0.7	NULL
0.41	NULL
19	NULL
LD	NULL
0.19	NULL
20	NULL
LD	NULL
1.41	NULL
1.06	NULL
21	NULL
LD	NULL
0.08	NULL
22	NULL
LD	NULL
0.13	NULL
23	NULL
LD	NULL
0.06	NULL
24	NULL
LD	NULL
0.07	NULL
25	NULL
LD	NULL
0.57	NULL
0.49	NULL
26	NULL
NS	NULL
0.13	NULL
4.8	NULL
27	NULL
NS	NULL
0.08	NULL
Control	NULL
cases	NULL
included	NULL
lymph	NULL
node	NULL
samples	NULL
with	NULL
CHD	NULL
from	NULL
5	NULL
patients	NULL
without	NULL
HIV	NULL
infection	NULL
.	NULL

The	NULL
median	NULL
tissue	NULL
CD4*/CD8+	NULL
cell	NULL
ratio	NULL
was	NULL
4.13	NULL
(	NULL
range	NULL
,	NULL
2.18-9.77	NULL
)	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
lymphocytes	NULL
expressing	NULL
CD4OL	NULL
was	NULL
38.2	NULL
%	NULL
,	NULL
52.79	NULL
%	NULL
,	NULL
67.85	NULL
%	NULL
,	NULL
72.2	NULL
%	NULL
,	NULL
and	NULL
75.12	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

*	NULL
The	NULL
percentage	NULL
of	NULL
lymphocytes	NULL
expressing	NULL
CD4OL	NULL
was	NULL
counted	NULL
on	NULL
the	NULL
total	NULL
of	NULL
CD3*	NULL
T	NULL
cells	NULL
.	NULL

fAnti-CD40L	NULL
MoAb	NULL
M90	NULL
was	NULL
applied	NULL
only	NULL
to	NULL
frozen	NULL
sections	NULL
(	NULL
12	NULL
cases	NULL
)	NULL
because	NULL
of	NULL
its	NULL
lack	NULL
of	NULL
reactivity	NULL
in	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
.	NULL

2321	NULL
naphthol	NULL
AS-MX	NULL
phosphate	NULL
along	NULL
with	NULL
fast	NULL
red	NULL
TR	NULL
salt	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
the	NULL
development	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
.	NULL

Analysis	NULL
of	NULL
Viral	NULL
Infection	NULL
All	NULL
HD	NULL
samples	NULL
included	NULL
in	NULL
the	NULL
study	NULL
were	NULL
subjected	NULL
to	NULL
determination	NULL
of	NULL
tumor	NULL
infection	NULL
by	NULL
EBV	NULL
.	NULL

EBER	NULL
in	NULL
situ	NULL
hybridization	NULL
studies	NULL
were	NULL
performed	NULL
on	NULL
HD	NULL
samples	NULL
to	NULL
identify	NULL
the	NULL
nature	NULL
and	NULL
distribution	NULL
of	NULL
EBV-infected	NULL
cells	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Hybridization	NULL
products	NULL
were	NULL
detected	NULL
using	NULL
an	NULL
anti-FITC	NULL
polyclonal	NULL
antibody-alkaline	NULL
phosphatase	NULL
conjugate	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Nitro	NULL
Blue	NULL
Tetra-zolium/5-bromo-4-chloro-3-indolyl	NULL
phosphate/p-iodonitrotetrazolium	NULL
violet	NULL
(	NULL
NBT/BCIP/INT	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
chromogen	NULL
.	NULL

In	NULL
all	NULL
samples	NULL
,	NULL
immunostaining	NULL
for	NULL
LMP1	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
LMP1-specific	NULL
antibody	NULL
(	NULL
Dako	NULL
)	NULL
on	NULL
Bouin-	NULL
or	NULL
Formalin-fixed	NULL
,	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
as	NULL
already	NULL
described	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
LMP1+*	NULL
neoplastic	NULL
cells	NULL
was	NULL
assigned	NULL
as	NULL
follows	NULL
:	NULL
0	NULL
%	NULL
,	NULL
less	NULL
than	NULL
10	NULL
%	NULL
,	NULL
10	NULL
%	NULL
to	NULL
25	NULL
%	NULL
,	NULL
25	NULL
%	NULL
to	NULL
50	NULL
%	NULL
,	NULL
50	NULL
%	NULL
to	NULL
75	NULL
%	NULL
,	NULL
and	NULL
greater	NULL
than	NULL
75	NULL
%	NULL
.	NULL

RESULTS	NULL
Expression	NULL
Profile	NULL
of	NULL
syn-1	NULL
and	NULL
BCL-6	NULL
in	NULL
HIV-HD	NULL
RS	NULL
cells	NULL
and	NULL
their	NULL
variants	NULL
expressed	NULL
syn-1	NULL
in	NULL
all	NULL
cases	NULL
of	NULL
HIV-HD	NULL
(	NULL
27	NULL
of	NULL
27	NULL
,	NULL
100	NULL
%	NULL
)	NULL
,	NULL
which	NULL
were	NULL
representative	NULL
of	NULL
the	NULL
entire	NULL
pathologic	NULL
spectrum	NULL
of	NULL
CHD	NULL
subtypes	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
syn-1*	NULL
RS	NULL
cells	NULL
was	NULL
variable	NULL
in	NULL
different	NULL
tumors	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
syn-1	NULL
immunoreactivity	NULL
in	NULL
RS	NULL
cells	NULL
was	NULL
consistent	NULL
with	NULL
cytoplasmic	NULL
and	NULL
membranous	NULL
staining	NULL
and	NULL
displayed	NULL
moderate	NULL
to	NULL
weak	NULL
staining	NULL
intensity	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
expression	NULL
of	NULL
BCL-6	NULL
by	NULL
RS	NULL
cells	NULL
was	NULL
negative	NULL
in	NULL
the	NULL
overwhelming	NULL
majority	NULL
of	NULL
HIV-HD	NULL
cases	NULL
(	NULL
25	NULL
of	NULL
27	NULL
,	NULL
92.6	NULL
%	NULL
)	NULL
.	NULL

Only	NULL
two	NULL
cases	NULL
of	NULL
HIV-HD	NULL
(	NULL
two	NULL
of	NULL
27	NULL
,	NULL
7.4	NULL
%	NULL
)	NULL
displayed	NULL
a	NULL
low	NULL
proportion	NULL
of	NULL
BCL-6+*	NULL
RS	NULL
cells	NULL
(	NULL
<	NULL
10	NULL
%	NULL
)	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
these	NULL
two	NULL
cases	NULL
containing	NULL
both	NULL
syn-1*	NULL
and	NULL
BCL-6+*	NULL
RS	NULL
cells	NULL
,	NULL
double-staining	NULL
experiments	NULL
demonstrated	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
antigens	NULL
was	NULL
mutually	NULL
exclusive	NULL
in	NULL
the	NULL
same	NULL
RS	NULL
cell	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
expression	NULL
in	NULL
each	NULL
individual	NULL
case	NULL
of	NULL
HD	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
dominant	NULL
phenotypic	NULL
profile	NULL
of	NULL
the	NULL
disease	NULL
,	NULL
which	NULL
was	NULL
characterized	NULL
by	NULL
BCL-6~/syn-1*	NULL
RS	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
BCL-6+/syn-1~	NULL
RS	NULL
cells	NULL
.	NULL

This	NULL
profile	NULL
clustered	NULL
with	NULL
25	NULL
of	NULL
27	NULL
(	NULL
92.6	NULL
%	NULL
)	NULL
cases	NULL
of	NULL
HIV-HD	NULL
.	NULL

A	NULL
less	NULL
frequent	NULL
phenotypic	NULL
profile	NULL
was	NULL
associated	NULL
with	NULL
two	NULL
of	NULL
27	NULL
(	NULL
7.4	NULL
%	NULL
)	NULL
cases	NULL
of	NULL
HIV-HD	NULL
;	NULL
it	NULL
was	NULL
characterized	NULL
by	NULL
a	NULL
predominant	NULL
population	NULL
of	NULL
BCL-6~-/syn-1*	NULL
RS	NULL
cells	NULL
coexisting	NULL
with	NULL
a	NULL
minor	NULL
(	NULL
<	NULL
10	NULL
%	NULL
)	NULL
population	NULL
of	NULL
BCL-6+*/syn-1~	NULL
RS	NULL
cells	NULL
in	NULL
the	NULL
same	NULL
biopsy	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Expression	NULL
Profile	NULL
of	NULL
LMP	NULL
1	NULL
in	NULL
HIV-HD	NULL
RS	NULL
cell	NULL
infection	NULL
by	NULL
EBV	NULL
was	NULL
scored	NULL
as	NULL
positive	NULL
in	NULL
25	NULL
of	NULL
27	NULL
(	NULL
92.6	NULL
%	NULL
)	NULL
HIV-HD	NULL
cases	NULL
assessed	NULL
by	NULL
EBER	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
Fig	NULL
1C	NULL
)	NULL
.	NULL

EBV	NULL
*	NULL
HIV-HD	NULL
cases	NULL
displayed	NULL
a	NULL
variable	NULL
proportion	NULL
of	NULL
RS	NULL
cells	NULL
expressing	NULL
LMP	NULL
1	NULL
(	NULL
Fig	NULL
1D	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
HIV-HD	NULL
cases	NULL
displaying	NULL
both	NULL
LMP1*	NULL
and	NULL
BCL-6+*	NULL
RS	NULL
cells	NULL
(	NULL
n	NULL
=	NULL
2	NULL
)	NULL
,	NULL
double-staining	NULL
experiments	NULL
ruled	NULL
out	NULL
the	NULL
coexpression	NULL
of	NULL
BCL-6	NULL
and	NULL
LMP1	NULL
by	NULL
the	NULL
same	NULL
RS	NULL
cell	NULL
(	NULL
Fig	NULL
1E	NULL
)	NULL
.	NULL

Both	NULL
cases	NULL
of	NULL
HIV-HD	NULL
lacking	NULL
infection	NULL
by	NULL
EBV	NULL
displayed	NULL
only	NULL
BCL-6~/	NULL
syn-1*	NULL
RS	NULL
cells	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
LMP1	NULL
expression	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
these	NULL
two	NULL
cases	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2322	NULL
&	NULL
€	NULL
®	NULL
toe	NULL
-	NULL
iy	NULL
$	NULL
©	NULL
©	NULL
‘	NULL
.	NULL

*	NULL
&	NULL
a	NULL
‘	NULL
J	NULL
‘	NULL
cg	NULL
)	NULL
?	NULL

9	NULL
‘	NULL
?	NULL

6	NULL
»	NULL
>	NULL
‘	NULL
Qk	NULL
”	NULL
;	NULL
@	NULL
&	NULL
&	NULL
n	NULL
)	NULL
.	NULL

‘	NULL
-	NULL
*	NULL
;	NULL
f	NULL
w'..	NULL
g	NULL
,	NULL
“	NULL
ﬁg	NULL
a*	NULL
*	NULL
*	NULL
#	NULL
to	NULL
®	NULL
“	NULL
ti	NULL
.	NULL

C	NULL
a*	NULL
Cous	NULL
®	NULL
ts	NULL
hees	NULL
$	NULL
74	NULL
2s	NULL
t	NULL
4	NULL
*	NULL
``	NULL
4	NULL
xg	NULL
ip	NULL
an	NULL
Rill	NULL
297	NULL
s*	NULL
q	NULL
if	NULL
”	NULL
)	NULL
?	NULL

ap	NULL
a	NULL
'd	NULL
st	NULL
w	NULL
#	NULL
#	NULL
.f	NULL
'	NULL
;	NULL
09-3	NULL
.	NULL

¥	NULL
SP	NULL
*	NULL
f	NULL
‘	NULL
g	NULL
'	NULL
h	NULL
}	NULL
i	NULL
.	NULL

4	NULL
)	NULL
Poa	NULL
*	NULL
a	NULL
sa	NULL
*	NULL
>	NULL
``	NULL
4	NULL
am	NULL
-	NULL
C	NULL
«	NULL
B	NULL
:	NULL
‘	NULL
Q	NULL
``	NULL
.	NULL

*	NULL
_	NULL
poro	NULL
f	NULL
>	NULL
ya	NULL
op	NULL
we	NULL
$	NULL
§	NULL
>	NULL
0	NULL
8	NULL
F	NULL
use	NULL
*	NULL
,	NULL
%	NULL
p	NULL
-*	NULL
C	NULL
t	NULL
I.	NULL
a	NULL
%	NULL
®	NULL
t	NULL
#	NULL
e	NULL
&	NULL
s	NULL
@	NULL
%	NULL
R	NULL
*	NULL
b	NULL
w	NULL
1	NULL
s	NULL
¥	NULL
(	NULL
a	NULL
)	NULL
;	NULL
at	NULL
``	NULL
t	NULL
at	NULL
€	NULL
{	NULL
a	NULL
4	NULL
z*	NULL
5	NULL
%	NULL
s	NULL
$	NULL
5	NULL
®	NULL
@	NULL
A	NULL
#	NULL
+	NULL
&	NULL
w	NULL
#	NULL
a	NULL
a	NULL
P	NULL
£	NULL
t	NULL
&	NULL
*a	NULL
%	NULL
%	NULL
-r	NULL
h	NULL
’	NULL
;	NULL
Pad	NULL
i	NULL
&	NULL
CARBONE	NULL
ET	NULL
AL	NULL
*a	NULL
w	NULL
'	NULL
m	NULL
*a	NULL
``	NULL
Phe	NULL
.	NULL

b	NULL
F	NULL
.	NULL

~	NULL
FD	NULL
o	NULL
e*	NULL
5g	NULL
5®	NULL
so	NULL
.	NULL

*	NULL
;	NULL
*	NULL
AD	NULL
:	NULL
.	NULL

N	NULL
*~	NULL
T	NULL
»	NULL
8	NULL
s	NULL
F	NULL
90	NULL
“	NULL
“	NULL
u	NULL
‘	NULL
»	NULL
``	NULL
0	NULL
’	NULL
_	NULL
#	NULL
#	NULL
.	NULL

@	NULL
..J	NULL
£0	NULL
:	NULL
‘	NULL
..	NULL
1	NULL
ai	NULL
#	NULL
*	NULL
‘	NULL
g.	NULL
‘	NULL
..	NULL
``	NULL
’	NULL
.	NULL

tas	NULL
p	NULL
``	NULL
NZ	NULL
,	NULL
``	NULL
523.333	NULL
:	NULL
``	NULL
.°	NULL
sf	NULL
®	NULL
ab	NULL
``	NULL
``	NULL
h	NULL
``	NULL
(	NULL
¢	NULL
,	NULL
&	NULL
|	NULL
_	NULL
»	NULL
Ade	NULL
t	NULL
p	NULL
tr	NULL
%	NULL
hip	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HIV-HD	NULL
NS	NULL
subtype	NULL
(	NULL
case	NULL
26	NULL
)	NULL
.	NULL

RS	NULL
cells	NULL
show	NULL
cytoplasmic	NULL
and	NULL
membranous	NULL
staining	NULL
of	NULL
variable	NULL
intensity	NULL
for	NULL
CD138/syn-1	NULL
in	NULL
Bouin-fixed	NULL
,	NULL
paraffin-~embedded	NULL
tissue	NULL
section	NULL
.	NULL

(	NULL
B	NULL
)	NULL
HIV-HD	NULL
MC	NULL
subtype	NULL
(	NULL
case	NULL
6	NULL
)	NULL
.	NULL

A	NULL
frozen	NULL
section	NULL
was	NULL
tested	NULL
by	NULL
2-color	NULL
staining	NULL
with	NULL
BCL-6	NULL
MoAb	NULL
and	NULL
syn-1	NULL
MoAb	NULL
.	NULL

A	NULL
BCL-6+	NULL
(	NULL
nuclear	NULL
,	NULL
blue	NULL
)	NULL
RS	NULL
cell	NULL
and	NULL
syn-1+*	NULL
(	NULL
cytoplasmic	NULL
and	NULL
membranous	NULL
,	NULL
red	NULL
)	NULL
RS	NULL
cells	NULL
(	NULL
arrows	NULL
)	NULL
are	NULL
present	NULL
.	NULL

No	NULL
coexpression	NULL
of	NULL
BCL-6	NULL
protein	NULL
is	NULL
detectable	NULL
in	NULL
syn-1+*	NULL
RS	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
,	NULL
D	NULL
)	NULL
HIV-HD	NULL
LD	NULL
subtype	NULL
(	NULL
case	NULL
25	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
RS	NULL
cells	NULL
show	NULL
EBV	NULL
positivity	NULL
by	NULL
EBER	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Signal	NULL
is	NULL
present	NULL
as	NULL
dense	NULL
brow	NULL
nish	NULL
grains	NULL
over	NULL
the	NULL
nuclei	NULL
of	NULL
RS	NULL
cells	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Most	NULL
RS	NULL
cells	NULL
display	NULL
strong	NULL
cytoplasmic	NULL
staining	NULL
for	NULL
the	NULL
EBV-encoded	NULL
LMP1	NULL
.	NULL

(	NULL
E	NULL
)	NULL
HIV-HD	NULL
MC	NULL
subtype	NULL
(	NULL
case	NULL
14	NULL
)	NULL
.	NULL

A	NULL
frozen	NULL
section	NULL
was	NULL
tested	NULL
by	NULL
2-color	NULL
staining	NULL
with	NULL
BCL-6	NULL
MoAb	NULL
and	NULL
LMP1	NULL
MoAb	NULL
.	NULL

An	NULL
RS	NULL
cell	NULL
exhibits	NULL
nuclear	NULL
staining	NULL
(	NULL
blue	NULL
)	NULL
for	NULL
BCL-6	NULL
(	NULL
at	NULL
left	NULL
)	NULL
,	NULL
w	NULL
hereas	NULL
another	NULL
RS	NULL
cell	NULL
show	NULL
s	NULL
cytoplasmic	NULL
and	NULL
membranous	NULL
staining	NULL
(	NULL
reddish	NULL
)	NULL
for	NULL
LM	NULL
P1	NULL
(	NULL
at	NULL
right	NULL
)	NULL
.	NULL

No	NULL
coexpression	NULL
of	NULL
both	NULL
markers	NULL
by	NULL
the	NULL
same	NULL
tumor	NULL
cell	NULL
is	NULL
detectable	NULL
.	NULL

(	NULL
A	NULL
,	NULL
D	NULL
)	NULL
APAAP	NULL
immunostaining	NULL
,	NULL
hematoxylin	NULL
counterstain	NULL
;	NULL
(	NULL
B	NULL
,	NULL
E	NULL
)	NULL
2-color	NULL
staining	NULL
,	NULL
no	NULL
counterstain	NULL
;	NULL
(	NULL
C	NULL
)	NULL
in	NULL
situ	NULL
hybridization	NULL
,	NULL
hematoxylin	NULL
counterstain	NULL
.	NULL

Original	NULL
magnification	NULL
x250	NULL
,	NULL
A-E.	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HISTOGENESIS	NULL
OF	NULL
HIV+	NULL
HODGKIN	NULL
'S	NULL
DISEASE	NULL
2323	NULL
Fig	NULL
2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HIV-HD	NULL
LD	NULL
subtype	NULL
(	NULL
case	NULL
25	NULL
)	NULL
.	NULL

Most	NULL
RS	NULL
cells	NULL
show	NULL
a	NULL
distinct	NULL
pattern	NULL
of	NULL
staining	NULL
for	NULL
anti-CD40	NULL
MoAb	NULL
89	NULL
:	NULL
a	NULL
strong	NULL
membranous	NULL
staining	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
dot-like	NULL
cytoplasmic	NULL
positivity	NULL
in	NULL
Bouin-fixed	NULL
,	NULL
paraffin-embedded	NULL
tissue	NULL
section	NULL
.	NULL

(	NULL
B	NULL
,	NULL
C	NULL
,	NULL
D	NULL
)	NULL
HIV-HD	NULL
MC	NULL
subtype	NULL
(	NULL
case	NULL
9	NULL
)	NULL
.	NULL

Serial	NULL
Bouin-fixed	NULL
,	NULL
paraffin-embedded	NULL
sections	NULL
show	NULL
that	NULL
in	NULL
the	NULL
same	NULL
area	NULL
containing	NULL
RS	NULL
cells	NULL
(	NULL
arrows	NULL
)	NULL
,	NULL
numerous	NULL
CD3+	NULL
(	NULL
B	NULL
)	NULL
and	NULL
CD8+	NULL
(	NULL
C	NULL
)	NULL
small	NULL
lymphocytes	NULL
are	NULL
present	NULL
in	NULL
the	NULL
cellular	NULL
background	NULL
,	NULL
where	NULL
cells	NULL
positive	NULL
for	NULL
CD4	NULL
(	NULL
D	NULL
)	NULL
are	NULL
scarce	NULL
.	NULL

(	NULL
E	NULL
)	NULL
HIV-HD	NULL
MC	NULL
subtype	NULL
(	NULL
case	NULL
1	NULL
)	NULL
.	NULL

CD4OL	NULL
positivity	NULL
is	NULL
manifested	NULL
on	NULL
frozen	NULL
section	NULL
as	NULL
dot-like	NULL
staining	NULL
on	NULL
scattered	NULL
lymphocytes	NULL
(	NULL
arrow	NULL
s	NULL
)	NULL
.	NULL

An	NULL
RS	NULL
cell	NULL
surrounded	NULL
by	NULL
CD40L-	NULL
lymphocytes	NULL
is	NULL
also	NULL
show	NULL
n	NULL
(	NULL
arrow	NULL
head	NULL
)	NULL
.	NULL

(	NULL
A	NULL
,	NULL
E	NULL
)	NULL
APAAP	NULL
immunostaining	NULL
;	NULL
(	NULL
B	NULL
,	NULL
C	NULL
,	NULL
D	NULL
)	NULL
ABC	NULL
immunostaining	NULL
;	NULL
(	NULL
A-E	NULL
)	NULL
hematoxylin	NULL
counterstain	NULL
.	NULL

Original	NULL
magnification	NULL
x250	NULL
(	NULL
A	NULL
)	NULL
,	NULL
x320	NULL
(	NULL
B-D	NULL
)	NULL
,	NULL
and	NULL
x400	NULL
(	NULL
E	NULL
)	NULL
.	NULL

I0O~OO	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2324	NULL
CD40/CD4O0L	NULL
Interactions	NULL
Between	NULL
RS	NULL
Cells	NULL
and	NULL
Reactive	NULL
T	NULL
Lymphocytes	NULL
in	NULL
HIV-HD	NULL
CD40	NULL
was	NULL
strongly	NULL
expressed	NULL
by	NULL
RS	NULL
cells	NULL
from	NULL
all	NULL
cases	NULL
of	NULL
HIV-HD	NULL
(	NULL
N=	NULL
27	NULL
)	NULL
,	NULL
which	NULL
were	NULL
representative	NULL
of	NULL
the	NULL
entire	NULL
pathologic	NULL
spectrum	NULL
of	NULL
CHD	NULL
subtypes	NULL
.	NULL

All	NULL
HIV-HD	NULL
cases	NULL
consistently	NULL
contained	NULL
more	NULL
than	NULL
50	NULL
%	NULL
CD40+*	NULL
RS	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
CD40	NULL
immunoreactivity	NULL
in	NULL
RS	NULL
cells	NULL
was	NULL
consistent	NULL
with	NULL
cytoplasmic	NULL
and	NULL
membranous	NULL
staining	NULL
and	NULL
displayed	NULL
strong	NULL
staining	NULL
intensity	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

With	NULL
respect	NULL
to	NULL
the	NULL
reactive	NULL
cellular	NULL
background	NULL
,	NULL
the	NULL
overwhelming	NULL
majority	NULL
of	NULL
HIV-HD	NULL
cases	NULL
demonstrated	NULL
inversion	NULL
of	NULL
the	NULL
CD4*/CD8*	NULL
T-cell	NULL
ratio	NULL
(	NULL
median	NULL
tissue	NULL
CD4+*/CD8+*	NULL
T-cell	NULL
ratio	NULL
,	NULL
0.2	NULL
;	NULL
range	NULL
,	NULL
0.05	NULL
to	NULL
1.47	NULL
;	NULL
Fig	NULL
2B	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
and	NULL
Table	NULL
2	NULL
)	NULL
in	NULL
all	NULL
morphologic	NULL
subtypes	NULL
and	NULL
all	NULL
conventional	NULL
phenotypes	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

Among	NULL
reactive	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
background	NULL
,	NULL
expression	NULL
of	NULL
CD40L	NULL
occurred	NULL
only	NULL
rarely	NULL
(	NULL
Fig	NULL
2E	NULL
and	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
rare	NULL
CD4O0L+*	NULL
T	NULL
lymphocytes	NULL
were	NULL
distributed	NULL
in	NULL
a	NULL
scattered	NULL
fashion	NULL
in	NULL
the	NULL
tumor	NULL
tissue	NULL
,	NULL
and	NULL
no	NULL
rosetting	NULL
of	NULL
RS	NULL
cells	NULL
by	NULL
CD40L+*	NULL
T	NULL
lymphocytes	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
any	NULL
of	NULL
the	NULL
fields	NULL
analyzed	NULL
.	NULL

Overall	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
stable	NULL
CD40/CDA40L	NULL
interaction	NULL
between	NULL
RS	NULL
cells	NULL
and	NULL
reactive	NULL
T	NULL
lymphocytes	NULL
is	NULL
not	NULL
a	NULL
feature	NULL
of	NULL
HIV-HD	NULL
.	NULL

DISCUSSION	NULL
The	NULL
aim	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
investigate	NULL
the	NULL
histogenesis	NULL
of	NULL
HIV-HD	NULL
.	NULL

The	NULL
implications	NULL
of	NULL
our	NULL
data	NULL
are	NULL
twofold	NULL
.	NULL

First	NULL
,	NULL
all	NULL
pathologic	NULL
variants	NULL
of	NULL
HIV-HD	NULL
are	NULL
histogenetically	NULL
homogeneous	NULL
and	NULL
reflect	NULL
a	NULL
post-GC	NULL
phenotype	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
histogenesis	NULL
differs	NULL
for	NULL
HIV-HD	NULL
versus	NULL
HD	NULL
in	NULL
the	NULL
general	NULL
population	NULL
because	NULL
of	NULL
differences	NULL
in	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
reactive	NULL
background	NULL
and	NULL
differences	NULL
intrinsic	NULL
to	NULL
the	NULL
neoplastic	NULL
clone	NULL
.	NULL

The	NULL
profile	NULL
of	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
expression	NULL
in	NULL
the	NULL
neoplastic	NULL
cells	NULL
of	NULL
HIV-HD	NULL
identifies	NULL
a	NULL
dominant	NULL
phenotypic	NULL
category	NULL
of	NULL
the	NULL
disease	NULL
,	NULL
represented	NULL
by	NULL
the	NULL
BCL-6~-/syn-1*	NULL
pattern	NULL
.	NULL

The	NULL
association	NULL
with	NULL
the	NULL
BCL-6~-/syn-1*	NULL
profile	NULL
suggests	NULL
that	NULL
RS	NULL
cells	NULL
of	NULL
HIV-HD	NULL
are	NULL
histogenetically	NULL
related	NULL
to	NULL
post-GC	NULL
B	NULL
cells	NULL
,	NULL
since	NULL
in	NULL
normal	NULL
lymphoid	NULL
tissues	NULL
,	NULL
the	NULL
BCL-6~/syn-1*	NULL
phenotypic	NULL
pattern	NULL
clusters	NULL
selectively	NULL
with	NULL
B	NULL
cells	NULL
that	NULL
have	NULL
exited	NULL
the	NULL
GC	NULL
and	NULL
are	NULL
differentiating	NULL
toward	NULL
the	NULL
late	NULL
stages	NULL
of	NULL
B-cell	NULL
maturation	NULL
.	NULL
``	NULL

The	NULL
BCL-6~-/syn-1*	NULL
phenotype	NULL
in	NULL
HIV-HD	NULL
occurs	NULL
throughout	NULL
the	NULL
pathologic	NULL
spectrum	NULL
of	NULL
the	NULL
disease	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
different	NULL
histologic	NULL
variants	NULL
of	NULL
HIV-HD	NULL
share	NULL
a	NULL
common	NULL
histogenetic	NULL
origin	NULL
and	NULL
the	NULL
morphologic	NULL
and	NULL
architectural	NULL
differences	NULL
are	NULL
not	NULL
directly	NULL
related	NULL
to	NULL
differences	NULL
in	NULL
histogenesis	NULL
.	NULL

The	NULL
BCL-6-/syn-1*	NULL
phenotype	NULL
of	NULL
HIV-HD	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
BCL-6*/syn-1~	NULL
phenotype	NULL
of	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
HD	NULL
,	NULL
but	NULL
resembles	NULL
the	NULL
BCL-6~/syn-1*	NULL
phenotype	NULL
displayed	NULL
by	NULL
the	NULL
majority	NULL
of	NULL
RS	NULL
cells	NULL
in	NULL
CHD	NULL
in	NULL
the	NULL
general	NULL
population	NULL
.	NULL
'	NULL

''	NULL
``	NULL
``	NULL
However	NULL
,	NULL
in	NULL
CHD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
,	NULL
BCL-6~/syn-1*	NULL
RS	NULL
cells	NULL
frequently	NULL
coexist	NULL
with	NULL
BCL-6*/syn-1~	NULL
RS	NULL
cells	NULL
in	NULL
the	NULL
same	NULL
biopsy	NULL
.	NULL
'	NULL

''	NULL
Conversely	NULL
,	NULL
the	NULL
coexistence	NULL
of	NULL
BCL-6~-/syn-1*	NULL
and	NULL
BCL-6+/syn-1~	NULL
RS	NULL
cells	NULL
is	NULL
exceptional	NULL
in	NULL
HIV-HD	NULL
.	NULL

Conceivably	NULL
,	NULL
these	NULL
phenotypic	NULL
differences	NULL
between	NULL
HIV-HD	NULL
and	NULL
CHD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
reflect	NULL
differences	NULL
in	NULL
the	NULL
tumor	NULL
microenvironment	NULL
or	NULL
in	NULL
the	NULL
neoplastic	NULL
clone	NULL
.	NULL

Signaling	NULL
between	NULL
neoplastic	NULL
and	NULL
reactive	NULL
cells	NULL
throughout	NULL
stable	NULL
CD40/CD4O0L	NULL
interactions	NULL
is	NULL
a	NULL
prominent	NULL
feature	NULL
of	NULL
CHD	NULL
CARBONE	NULL
ET	NULL
AL	NULL
of	NULL
the	NULL
general	NULL
population	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Because	NULL
triggering	NULL
of	NULL
CD40	NULL
causes	NULL
downregulation	NULL
of	NULL
BCL-6	NULL
expression	NULL
,	NULL
``	NULL
>	NULL
``	NULL
``	NULL
CD40/CD40L	NULL
signaling	NULL
is	NULL
regarded	NULL
as	NULL
a	NULL
major	NULL
determinant	NULL
of	NULL
the	NULL
RS	NULL
cell	NULL
phenotype	NULL
in	NULL
the	NULL
context	NULL
of	NULL
CHD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
RS	NULL
cells	NULL
of	NULL
HIV-HD	NULL
express	NULL
CD40	NULL
,	NULL
CD4OL+*	NULL
T	NULL
lymphocytes	NULL
are	NULL
rare	NULL
in	NULL
this	NULL
form	NULL
of	NULL
the	NULL
disease	NULL
,	NULL
most	NULL
likely	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
CD4*	NULL
T-cell	NULL
depletion	NULL
induced	NULL
by	NULL
HIV	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
HIV-HD	NULL
is	NULL
characteristically	NULL
devoid	NULL
of	NULL
CD4O0L+	NULL
T	NULL
lymphocytes	NULL
surrounding	NULL
RS	NULL
cells	NULL
,	NULL
a	NULL
phenomenon	NULL
known	NULL
as	NULL
rosetting	NULL
and	NULL
strictly	NULL
correlated	NULL
with	NULL
the	NULL
BCL-6~-/syn-1	NULL
*	NULL
phenotype	NULL
in	NULL
CHD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
.	NULL
'	NULL

''	NULL
These	NULL
data	NULL
suggest	NULL
that	NULL
if	NULL
CD40/CD40L	NULL
interactions	NULL
occur	NULL
in	NULL
HIV-HD	NULL
,	NULL
they	NULL
are	NULL
most	NULL
likely	NULL
transient	NULL
and	NULL
are	NULL
not	NULL
characterized	NULL
by	NULL
the	NULL
stability	NULL
displayed	NULL
by	NULL
similar	NULL
interactions	NULL
in	NULL
CHD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
.	NULL

Because	NULL
RS	NULL
cells	NULL
of	NULL
HIV-HD	NULL
express	NULL
LMP	NULL
1	NULL
in	NULL
the	NULL
overwhelming	NULL
majority	NULL
of	NULL
cases	NULL
(	NULL
this	NULL
study	NULL
and	NULL
others®*	NULL
)	NULL
and	NULL
because	NULL
LMP1	NULL
is	NULL
able	NULL
to	NULL
downregulate	NULL
BCL-6	NULL
in	NULL
B	NULL
cells	NULL
with	NULL
a	NULL
GC	NULL
phenotype	NULL
,	NULL
``	NULL
``	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
LMP1	NULL
contributes	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
to	NULL
modulation	NULL
of	NULL
the	NULL
HIV-HD	NULL
phenotype	NULL
.	NULL

Although	NULL
a	NULL
formal	NULL
proof	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
LMP1	NULL
pathway	NULL
in	NULL
HIV-HD	NULL
is	NULL
presently	NULL
lacking	NULL
,	NULL
recent	NULL
data	NULL
obtained	NULL
in	NULL
HIV-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
have	NULL
demonstrated	NULL
that	NULL
LMP1	NULL
,	NULL
when	NULL
present	NULL
,	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
its	NULL
corresponding	NULL
downstream	NULL
signaling	NULL
cascade	NULL
.	NULL
``	NULL

''	NULL
In	NULL
vivo	NULL
,	NULL
neoplastic	NULL
B	NULL
cells	NULL
expressing	NULL
LMP1	NULL
display	NULL
the	NULL
BCL-6~/syn-1*	NULL
phenotype	NULL
and	NULL
are	NULL
thought	NULL
to	NULL
reflect	NULL
post-GC	NULL
immunoblasts	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
,	NULL
as	NULL
opposed	NULL
to	NULL
GC-unrelated	NULL
immuno-pre-GC	NULL
B-cells	NULL
GC	NULL
B-cells	NULL
post-GC	NULL
B-cells	NULL
@	NULL
|	NULL
BCL-6*	NULL
BCL-6~	NULL
SYN-1-	NULL
SYN-1*	NULL
LMP-1-	NULL
LMP-1*	NULL
HIV-SNCCL	NULL
HIV-HD	NULL
HIV-LNCCL	NULL
HIV-IBPL	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Histogenetic	NULL
model	NULL
for	NULL
HIV-associated	NULL
lymphoproliferative	NULL
disorders	NULL
infected	NULL
by	NULL
EBV	NULL
(	NULL
Carbone	NULL
et	NULL
al	NULL
``	NULL
``	NULL
and	NULL
this	NULL
study	NULL
)	NULL
.	NULL

The	NULL
proposed	NULL
model	NULL
is	NULL
based	NULL
on	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
and	NULL
CD138/syn-1	NULL
throughout	NULL
physiologic	NULL
B-cell	NULL
differentiation	NULL
.	NULL

B	NULL
cells	NULL
within	NULL
the	NULL
GC	NULL
display	NULL
the	NULL
BCL-6+/syn-1~	NULL
phenotype	NULL
,	NULL
whereas	NULL
B	NULL
cells	NULL
that	NULL
have	NULL
exited	NULL
the	NULL
GC	NULL
and	NULL
further	NULL
matured	NULL
toward	NULL
the	NULL
plasma	NULL
cell	NULL
stage	NULL
exhibit	NULL
the	NULL
BCL-6~/syn-1*	NULL
phenotype	NULL
.	NULL

On	NULL
these	NULL
bases	NULL
,	NULL
HIV-associated	NULL
systemic	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
displaying	NULL
the	NULL
BCL-6+/syn-1~	NULL
phenotype	NULL
,	NULL
ie	NULL
,	NULL
HIV-associated	NULL
small	NULL
noncleaved	NULL
cell	NULL
lymphoma	NULL
(	NULL
HIV-SNCCL	NULL
)	NULL
and	NULL
HIV-associated	NULL
large	NULL
noncleaved	NULL
cell	NULL
lymphoma	NULL
(	NULL
HIV-LNCCL	NULL
)	NULL
,	NULL
are	NULL
postulated	NULL
to	NULL
originate	NULL
from	NULL
GC	NULL
B	NULL
cells	NULL
.	NULL

Conversely	NULL
,	NULL
HIV-associated	NULL
lymphomas	NULL
displaying	NULL
the	NULL
BCL-6-/	NULL
syn-1*	NULL
phenotype	NULL
,	NULL
ie	NULL
,	NULL
HIV-associated	NULL
immunoblastic	NULL
plasmacytoid	NULL
lymphoma	NULL
(	NULL
HIV-IBPL	NULL
)	NULL
and	NULL
HIV-HD	NULL
,	NULL
are	NULL
postulated	NULL
to	NULL
derive	NULL
from	NULL
B	NULL
cells	NULL
that	NULL
have	NULL
transited	NULL
through	NULL
the	NULL
GC	NULL
and	NULL
have	NULL
undergone	NULL
preterminal	NULL
differentiation	NULL
.	NULL

The	NULL
post-GC	NULL
nature	NULL
of	NULL
these	NULL
lymphomas	NULL
is	NULL
formally	NULL
documented	NULL
,	NULL
at	NULL
least	NULL
in	NULL
the	NULL
case	NULL
of	NULL
AIDS-IBPL	NULL
,	NULL
by	NULL
the	NULL
association	NULL
with	NULL
genotypic	NULL
markers	NULL
of	NULL
GC	NULL
transit	NULL
,	NULL
namely	NULL
somatic	NULL
hypermutation	NULL
of	NULL
Ig	NULL
genes	NULL
and	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5°	NULL
noncoding	NULL
regions	NULL
.	NULL

The	NULL
BCL-6-/syn-1+*	NULL
phenotype	NULL
is	NULL
permissive	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
EBV-encoded	NULL
LMP1	NULL
antigen	NULL
.	NULL

Conversely	NULL
,	NULL
LMP1	NULL
expression	NULL
is	NULL
consistently	NULL
absent	NULL
among	NULL
HIV-associated	NULL
lymphomas	NULL
displaying	NULL
the	NULL
BCL-6+/	NULL
syn-1~	NULL
phenotype	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HISTOGENESIS	NULL
OF	NULL
HIV+	NULL
HODGKIN	NULL
'S	NULL
DISEASE	NULL
blasts	NULL
,	NULL
based	NULL
on	NULL
their	NULL
association	NULL
with	NULL
genotypic	NULL
markers	NULL
of	NULL
B-cell	NULL
transit	NULL
through	NULL
the	NULL
GC	NULL
,	NULL
including	NULL
mutations	NULL
of	NULL
Ig	NULL
variable	NULL
genes	NULL
and	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
``	NULL
noncoding	NULL
regions	NULL
.	NULL
``	NULL

The	NULL
BCL-6~/syn-1*	NULL
phenotype	NULL
is	NULL
also	NULL
expressed	NULL
by	NULL
a	NULL
significant	NULL
proportion	NULL
of	NULL
RS	NULL
cells	NULL
of	NULL
CHD	NULL
of	NULL
the	NULL
general	NULL
population	NULL
,	NULL
which	NULL
may	NULL
be	NULL
considered	NULL
post-GC	NULL
cells	NULL
since	NULL
they	NULL
harbor	NULL
mutations	NULL
of	NULL
Ig	NULL
variable	NULL
genes	NULL
and	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
These	NULL
observations	NULL
suggest	NULL
that	NULL
BCL-6~/syn-1*/	NULL
LMP1+	NULL
RS	NULL
cells	NULL
of	NULL
HIV-HD	NULL
are	NULL
also	NULL
derived	NULL
from	NULL
post-GC	NULL
cells	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
,	NULL
although	NULL
a	NULL
formal	NULL
demonstration	NULL
of	NULL
their	NULL
association	NULL
with	NULL
genotypic	NULL
markers	NULL
of	NULL
GC	NULL
transition	NULL
is	NULL
presently	NULL
lacking	NULL
.	NULL

On	NULL
these	NULL
bases	NULL
,	NULL
it	NULL
may	NULL
be	NULL
postulated	NULL
that	NULL
LMP1	NULL
expression	NULL
contributes	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
to	NULL
modulation	NULL
of	NULL
the	NULL
RS	NULL
cell	NULL
phenotype	NULL
in	NULL
HIV-HD	NULL
.	NULL

According	NULL
to	NULL
this	NULL
model	NULL
,	NULL
LMP1	NULL
expres-sion	NULL
,	NULL
presumably	NULL
in	NULL
cooperation	NULL
with	NULL
other	NULL
cellular	NULL
signals	NULL
,	NULL
would	NULL
induce	NULL
RS	NULL
cells	NULL
to	NULL
downregulate	NULL
BCL-6	NULL
,	NULL
thus	NULL
allowing	NULL
further	NULL
maturation	NULL
of	NULL
the	NULL
tumor	NULL
clone	NULL
to	NULL
assume	NULL
a	NULL
post-GC	NULL
phenotype	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

This	NULL
model	NULL
prompts	NULL
investigations	NULL
aimed	NULL
at	NULL
dissecting	NULL
the	NULL
signaling	NULL
cascade	NULL
mediated	NULL
by	NULL
LMP1	NULL
in	NULL
the	NULL
context	NULL
of	NULL
HIV-HD	NULL
and	NULL
at	NULL
defining	NULL
the	NULL
precise	NULL
pathway	NULL
exploited	NULL
for	NULL
the	NULL
modulation	NULL
of	NULL
RS	NULL
cell	NULL
phenotype	NULL
in	NULL
hosts	NULL
infected	NULL
with	NULL
HIV	NULL
.	NULL
``	NULL

REFERENCES	NULL
1	NULL
.	NULL

Serraino	NULL
D	NULL
,	NULL
Pezzotti	NULL
P	NULL
,	NULL
Dorrucci	NULL
M	NULL
,	NULL
Alliegro	NULL
MB	NULL
,	NULL
Sinicco	NULL
A	NULL
,	NULL
Rezza	NULL
G	NULL
:	NULL
Cancer	NULL
incidence	NULL
in	NULL
a	NULL
cohort	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
seroconverters	NULL
.	NULL

HIV	NULL
Italian	NULL
Seroconversion	NULL
Study	NULL
Group	NULL
.	NULL

Cancer	NULL
79:1004	NULL
,	NULL
1997	NULL
2	NULL
.	NULL

Goedert	NULL
JJ	NULL
,	NULL
Coté	NULL
TR	NULL
,	NULL
Virgo	NULL
P	NULL
,	NULL
Scoppa	NULL
SM	NULL
,	NULL
Kingma	NULL
DW	NULL
,	NULL
Gail	NULL
MH	NULL
,	NULL
Jaffe	NULL
ES	NULL
,	NULL
Biggar	NULL
RJ	NULL
,	NULL
for	NULL
the	NULL
AIDS-Cancer	NULL
Match	NULL
Study	NULL
Group	NULL
:	NULL
Spectrum	NULL
of	NULL
AIDS-associated	NULL
malignant	NULL
disorders	NULL
.	NULL

Lancet	NULL
351:1833	NULL
,	NULL
1998	NULL
3	NULL
.	NULL

Tirelli	NULL
U	NULL
,	NULL
Errante	NULL
D	NULL
,	NULL
Dolcetti	NULL
R	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Serraino	NULL
D	NULL
,	NULL
Vaccher	NULL
E	NULL
,	NULL
Franceschi	NULL
S	NULL
,	NULL
Boiocchi	NULL
M	NULL
,	NULL
Carbone	NULL
A	NULL
:	NULL
Hodgkin	NULL
's	NULL
disease	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
:	NULL
Clinicopathologic	NULL
and	NULL
virologic	NULL
features	NULL
of	NULL
114	NULL
patients	NULL
from	NULL
the	NULL
Italian	NULL
Cooperative	NULL
Group	NULL
on	NULL
AIDS	NULL
and	NULL
Tumors	NULL
.	NULL

J	NULL
Clin	NULL
Oncol	NULL
13:1758	NULL
,	NULL
1995	NULL
4	NULL
.	NULL

Ree	NULL
HJ	NULL
,	NULL
Strauchen	NULL
JA	NULL
,	NULL
Khan	NULL
AA	NULL
,	NULL
Gold	NULL
JE	NULL
,	NULL
Crowley	NULL
JP	NULL
,	NULL
Khan	NULL
H	NULL
,	NULL
Zalusky	NULL
R	NULL
:	NULL
Human	NULL
immunodeficiency	NULL
virus-associated	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Clinicopathologic	NULL
studies	NULL
of	NULL
24	NULL
cases	NULL
and	NULL
preponderance	NULL
of	NULL
mixed	NULL
cellularity	NULL
type	NULL
characterized	NULL
by	NULL
the	NULL
occurrence	NULL
of	NULL
fibrohistiocytoid	NULL
stromal	NULL
cells	NULL
.	NULL

Cancer	NULL
67:1614	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Uccini	NULL
S	NULL
,	NULL
Monardo	NULL
F	NULL
,	NULL
Ruco	NULL
LP	NULL
,	NULL
Baroni	NULL
CD	NULL
,	NULL
Faggioni	NULL
A	NULL
,	NULL
Agliano	NULL
AM	NULL
,	NULL
Gradilone	NULL
A	NULL
,	NULL
Manzari	NULL
V	NULL
,	NULL
Vago	NULL
L	NULL
,	NULL
Costanzi	NULL
G	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Boiocchi	NULL
M	NULL
,	NULL
De	NULL
Re	NULL
V	NULL
:	NULL
High	NULL
frequency	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
in	NULL
HIV-positive	NULL
patients	NULL
with	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Lancet	NULL
1:1458	NULL
,	NULL
1989	NULL
6	NULL
.	NULL

Audouin	NULL
J	NULL
,	NULL
Diebold	NULL
J	NULL
,	NULL
Pallesen	NULL
G	NULL
:	NULL
Frequent	NULL
expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
in	NULL
tumour	NULL
cells	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
in	NULL
HIV-positive	NULL
patients	NULL
.	NULL

J	NULL
Pathol	NULL
167:381	NULL
,	NULL
1992	NULL
7	NULL
.	NULL

Herndier	NULL
BG	NULL
,	NULL
Sanchez	NULL
HC	NULL
,	NULL
Chang	NULL
KL	NULL
,	NULL
Chen	NULL
YY	NULL
,	NULL
Weiss	NULL
LM	NULL
:	NULL
High	NULL
prevalence	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
in	NULL
the	NULL
Reed-Sternberg	NULL
cells	NULL
of	NULL
HIV-associated	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
142:1073	NULL
,	NULL
1993	NULL
8	NULL
.	NULL

IARC	NULL
Monographs	NULL
on	NULL
the	NULL
Evaluation	NULL
of	NULL
Carcinogenic	NULL
Risks	NULL
to	NULL
Humans	NULL
,	NULL
vol	NULL
67	NULL
:	NULL
Human	NULL
Immunodeficiency	NULL
Viruses	NULL
and	NULL
Human	NULL
T-Cell	NULL
Lymphotropic	NULL
Viruses	NULL
.	NULL

International	NULL
Agency	NULL
for	NULL
Research	NULL
on	NULL
Cancer/	NULL
World	NULL
Health	NULL
Organization	NULL
,	NULL
Lyon	NULL
,	NULL
France	NULL
,	NULL
1996	NULL
9	NULL
.	NULL

Unger	NULL
P	NULL
,	NULL
Strauchen	NULL
JA	NULL
:	NULL
Hodgkin	NULL
's	NULL
disease	NULL
in	NULL
AIDS	NULL
complex	NULL
patients	NULL
.	NULL

Report	NULL
of	NULL
four	NULL
cases	NULL
and	NULL
tissue	NULL
immunologic	NULL
marker	NULL
studies	NULL
.	NULL

Cancer	NULL
58:821	NULL
,	NULL
1986	NULL
10	NULL
.	NULL

Knowles	NULL
DM	NULL
,	NULL
Chamulak	NULL
GA	NULL
,	NULL
Subar	NULL
M	NULL
,	NULL
Burke	NULL
JS	NULL
,	NULL
Dugan	NULL
M	NULL
,	NULL
Wenz	NULL
J	NULL
,	NULL
Slywotzky	NULL
C	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Raphael	NULL
B	NULL
:	NULL
2325	NULL
Lymphoid	NULL
neoplasia	NULL
associated	NULL
with	NULL
the	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
.	NULL

Ann	NULL
Intern	NULL
Med	NULL
108:744	NULL
,	NULL
1988	NULL
11	NULL
.	NULL

Pelstring	NULL
RJ	NULL
,	NULL
Zellmer	NULL
RB	NULL
,	NULL
Sulak	NULL
LB	NULL
,	NULL
Banks	NULL
PM	NULL
,	NULL
Clare	NULL
N	NULL
:	NULL
Hodgkin	NULL
's	NULL
disease	NULL
in	NULL
association	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
.	NULL

Pathologic	NULL
and	NULL
immunologic	NULL
features	NULL
.	NULL

Cancer	NULL
67:1865	NULL
,	NULL
1991	NULL
12	NULL
.	NULL

Kiippers	NULL
R	NULL
,	NULL
Rajewsky	NULL
K	NULL
,	NULL
Zhao	NULL
M	NULL
,	NULL
Simons	NULL
G	NULL
,	NULL
Laumann	NULL
R	NULL
,	NULL
Fischer	NULL
R	NULL
,	NULL
Hansmann	NULL
M-L	NULL
:	NULL
Hodgkin	NULL
disease	NULL
:	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
picked	NULL
from	NULL
histological	NULL
sections	NULL
show	NULL
clonal	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
and	NULL
appear	NULL
to	NULL
be	NULL
derived	NULL
from	NULL
B	NULL
cells	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
development	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:10962	NULL
,	NULL
1994	NULL
13	NULL
.	NULL

Hummel	NULL
M	NULL
,	NULL
Ziemann	NULL
K	NULL
,	NULL
Lammert	NULL
H	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Sabattini	NULL
B	NULL
,	NULL
Stein	NULL
H	NULL
:	NULL
Hodgkin	NULL
's	NULL
disease	NULL
with	NULL
monoclonal	NULL
and	NULL
polyclonal	NULL
populations	NULL
of	NULL
Reed-Sternberg	NULL
cells	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
333:901	NULL
,	NULL
1995	NULL
14	NULL
.	NULL

Kanzler	NULL
H	NULL
,	NULL
Kiippers	NULL
R	NULL
,	NULL
Hansmann	NULL
M-L	NULL
,	NULL
Rajewsky	NULL
K	NULL
:	NULL
Hodgkin	NULL
and	NULL
Reed-Stemmberg	NULL
cells	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
represent	NULL
the	NULL
outgrowth	NULL
of	NULL
a	NULL
dominant	NULL
tumor	NULL
clone	NULL
derived	NULL
from	NULL
(	NULL
crippled	NULL
)	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
184:1495	NULL
,	NULL
1996	NULL
15	NULL
.	NULL

Marafioti	NULL
T	NULL
,	NULL
Hummel	NULL
M	NULL
,	NULL
Anagnostopoulos	NULL
I	NULL
,	NULL
Foss	NULL
HD	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Delsol	NULL
G	NULL
,	NULL
Isaacson	NULL
PG	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Stein	NULL
H	NULL
:	NULL
Origin	NULL
of	NULL
nodular	NULL
lymphocyte-predominant	NULL
Hodgkin	NULL
's	NULL
disease	NULL
from	NULL
a	NULL
clonal	NULL
expansion	NULL
of	NULL
highly	NULL
mutated	NULL
germinal-center	NULL
B-cells	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
337:453	NULL
,	NULL
1997	NULL
16	NULL
.	NULL

Ohno	NULL
T	NULL
,	NULL
Stribley	NULL
JA	NULL
,	NULL
Wu	NULL
G	NULL
,	NULL
Hinrichs	NULL
SH	NULL
,	NULL
Weisenburger	NULL
DD	NULL
,	NULL
Chan	NULL
WC	NULL
:	NULL
Clonality	NULL
in	NULL
nodular	NULL
lymphocyte-predominant	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
337:459	NULL
,	NULL
1997	NULL
17	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Franceschi	NULL
S	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Drexler	NULL
HG	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Expression	NULL
status	NULL
of	NULL
BCL-6	NULL
and	NULL
syndecan-1	NULL
identifies	NULL
distinct	NULL
histogenetic	NULL
subtypes	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Blood	NULL
92:2220	NULL
,	NULL
1998	NULL
18	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Lista	NULL
F	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Alterations	NULL
of	NULL
BCL-6	NULL
,	NULL
a	NULL
novel	NULL
zinc-finger	NULL
gene	NULL
,	NULL
in	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
.	NULL

Science	NULL
262:747	NULL
,	NULL
1993	NULL
19	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Shen	NULL
Q	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Hawe	NULL
N	NULL
,	NULL
de	NULL
Waard	NULL
R	NULL
,	NULL
Leung	NULL
C	NULL
,	NULL
Nouri-Shirazi	NULL
M	NULL
,	NULL
Orazi	NULL
A	NULL
,	NULL
Chaganti	NULL
RS	NULL
,	NULL
Rothman	NULL
P	NULL
,	NULL
Stall	NULL
AM	NULL
,	NULL
Pandolfi	NULL
PP	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
The	NULL
BCL-6	NULL
proto-oncogene	NULL
controls	NULL
germinal-centre	NULL
formation	NULL
and	NULL
Th2-type	NULL
inflammation	NULL
.	NULL

Nat	NULL
Genet	NULL
16:161	NULL
,	NULL
1997	NULL
20	NULL
.	NULL

Flenghi	NULL
L	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Fizzotti	NULL
M	NULL
,	NULL
Bigemna	NULL
B	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Venturi	NULL
S	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Pescarmona	NULL
E	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
A	NULL
specific	NULL
monoclonal	NULL
antibody	NULL
(	NULL
PG-B6	NULL
)	NULL
detects	NULL
expression	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
147:405	NULL
,	NULL
1995	NULL
21	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Larocca	NULL
LM	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Canzonieri	NULL
V	NULL
,	NULL
Antinori	NULL
A	NULL
,	NULL
Tirelli	NULL
U	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
BCL-6	NULL
,	NULL
CD138/syndecan-1	NULL
and	NULL
EBV-encoded	NULL
latent	NULL
membrane	NULL
protein-1	NULL
identifies	NULL
distinct	NULL
histogenetic	NULL
subsets	NULL
of	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Blood	NULL
91:747	NULL
,	NULL
1998	NULL
22	NULL
.	NULL

Allman	NULL
D	NULL
,	NULL
Jain	NULL
A	NULL
,	NULL
Dent	NULL
A	NULL
,	NULL
Maile	NULL
RR	NULL
,	NULL
Selvaggi	NULL
T	NULL
,	NULL
Kehry	NULL
MR	NULL
,	NULL
Staudt	NULL
LM	NULL
:	NULL
BCL-6	NULL
expression	NULL
during	NULL
B-cell	NULL
activation	NULL
.	NULL

Blood	NULL
87:5257	NULL
,	NULL
1996	NULL
23	NULL
.	NULL

Cattoretti	NULL
G	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Cleary	NULL
AM	NULL
,	NULL
Lederman	NULL
S	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Downregulation	NULL
of	NULL
BCL-6	NULL
gene	NULL
expression	NULL
by	NULL
CD40	NULL
and	NULL
EBV	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP-1	NULL
)	NULL
and	NULL
its	NULL
block	NULL
in	NULL
lymphoma	NULL
carrying	NULL
BCL-6	NULL
rearrangements	NULL
.	NULL

Blood	NULL
90:175a	NULL
,	NULL
1997	NULL
(	NULL
abstr	NULL
)	NULL
24	NULL
.	NULL

Wijdenes	NULL
J	NULL
,	NULL
Vooijs	NULL
WC	NULL
,	NULL
Clément	NULL
C	NULL
,	NULL
Post	NULL
J	NULL
,	NULL
Morard	NULL
F	NULL
,	NULL
Vita	NULL
N	NULL
,	NULL
Laurent	NULL
P	NULL
,	NULL
Sun	NULL
R-X	NULL
,	NULL
Klein	NULL
B	NULL
,	NULL
Dore	NULL
J-M	NULL
:	NULL
A	NULL
plasmocyte	NULL
selective	NULL
monoclonal	NULL
antibody	NULL
(	NULL
B-B4	NULL
)	NULL
recognizes	NULL
syndecan-1	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
94:318	NULL
,	NULL
1996	NULL
25	NULL
.	NULL

Harris	NULL
NL	NULL
,	NULL
Jaffe	NULL
ES	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Banks	NULL
PM	NULL
,	NULL
Chan	NULL
JKC	NULL
,	NULL
Cleary	NULL
ML	NULL
,	NULL
Delsol	NULL
G	NULL
,	NULL
De	NULL
Wolf-Peeters	NULL
C	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Gatter	NULL
KC	NULL
,	NULL
Grogan	NULL
TM	NULL
,	NULL
Isaacson	NULL
PG	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Mason	NULL
DY	NULL
,	NULL
Muller-Hermelink	NULL
H-K	NULL
,	NULL
Pileri	NULL
SA	NULL
,	NULL
Piris	NULL
MA	NULL
,	NULL
Ralfkiaer	NULL
E	NULL
,	NULL
Warnke	NULL
RA	NULL
:	NULL
A	NULL
revised	NULL
European-American	NULL
classification	NULL
of	NULL
lymphoid	NULL
neoplasms	NULL
:	NULL
A	NULL
proposal	NULL
from	NULL
the	NULL
International	NULL
Lymphoma	NULL
Study	NULL
Group	NULL
.	NULL

Blood	NULL
84:1361	NULL
,	NULL
1994	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2326	NULL
26	NULL
.	NULL

Lukes	NULL
RJ	NULL
,	NULL
Craver	NULL
LF	NULL
,	NULL
Hall	NULL
TC	NULL
,	NULL
Rappaport	NULL
H	NULL
,	NULL
Ruben	NULL
P	NULL
:	NULL
Report	NULL
of	NULL
the	NULL
Nomenclature	NULL
Committee	NULL
.	NULL

Cancer	NULL
Res	NULL
26:1311	NULL
,	NULL
1966	NULL
27	NULL
.	NULL

Lukes	NULL
RJ	NULL
,	NULL
Butler	NULL
JJ	NULL
,	NULL
Hicks	NULL
EB	NULL
:	NULL
Natural	NULL
history	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
as	NULL
related	NULL
to	NULL
its	NULL
pathologic	NULL
picture	NULL
.	NULL

Cancer	NULL
19:317	NULL
,	NULL
1966	NULL
28	NULL
.	NULL

Neiman	NULL
RS	NULL
:	NULL
Current	NULL
problems	NULL
in	NULL
the	NULL
histopathologic	NULL
diagnosis	NULL
and	NULL
classification	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
,	NULL
in	NULL
Sommers	NULL
SC	NULL
,	NULL
Rosen	NULL
PP	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Pathology	NULL
Annual	NULL
.	NULL

Norwalk	NULL
,	NULL
CT	NULL
,	NULL
Appleton-Century-Crofts	NULL
,	NULL
1978	NULL
,	NULL
p	NULL
289	NULL
29	NULL
.	NULL

Cordell	NULL
JL	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Erber	NULL
WN	NULL
,	NULL
Ghosh	NULL
AK	NULL
,	NULL
Abdulaziz	NULL
Z	NULL
,	NULL
MacDonald	NULL
S	NULL
,	NULL
Pulford	NULL
KAF	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Mason	NULL
DY	NULL
:	NULL
Immuncenzymatic	NULL
labelling	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
using	NULL
immune	NULL
complexes	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
monoclonal	NULL
antialkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
com-plexes	NULL
)	NULL
.	NULL

J	NULL
Histochem	NULL
Cytochem	NULL
32:219	NULL
,	NULL
1984	NULL
30	NULL
.	NULL

Flenghi	NULL
L	NULL
,	NULL
Bigerna	NULL
B	NULL
,	NULL
Fizzotti	NULL
M	NULL
,	NULL
Venturi	NULL
S	NULL
,	NULL
Pasqualucci	NULL
L	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Gambacorta	NULL
M	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Baroni	NULL
CD	NULL
,	NULL
Pescarmona	NULL
E	NULL
,	NULL
Anagnostopoulos	NULL
I	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Asdrubali	NULL
G	NULL
,	NULL
Martelli	NULL
MF	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
Monoclonal	NULL
antibodies	NULL
PG-B6a	NULL
and	NULL
PG-B6b	NULL
recognize	NULL
,	NULL
respectively	NULL
,	NULL
a	NULL
highly	NULL
conserved	NULL
and	NULL
a	NULL
Formol-resistant	NULL
epitope	NULL
on	NULL
the	NULL
human	NULL
BCL-6	NULL
protein	NULL
amino-terminal	NULL
region	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
148:1543	NULL
,	NULL
1996	NULL
31	NULL
.	NULL

Hsu	NULL
S-M	NULL
,	NULL
Raine	NULL
L	NULL
,	NULL
Fanger	NULL
H	NULL
;	NULL
A	NULL
comparative	NULL
study	NULL
of	NULL
the	NULL
peroxidase-antiperoxidase	NULL
method	NULL
and	NULL
an	NULL
avidin-biotin	NULL
complex	NULL
method	NULL
for	NULL
studying	NULL
polypeptide	NULL
hormones	NULL
with	NULL
radioimmunoassay	NULL
antibodies	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
75:734	NULL
,	NULL
1981	NULL
32	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Volpe	NULL
R	NULL
:	NULL
Immunchistochemistry	NULL
of	NULL
Hodgkin	NULL
and	NULL
non-Hodgkin	NULL
lymphomas	NULL
with	NULL
emphasis	NULL
on	NULL
the	NULL
diagnostic	NULL
significance	NULL
of	NULL
the	NULL
BNH	NULL
antibody	NULL
reactivity	NULL
with	NULL
anaplastic	NULL
large	NULL
cell	NULL
(	NULL
CD30	NULL
positive	NULL
)	NULL
lymphomas	NULL
.	NULL

Cancer	NULL
70:2691	NULL
,	NULL
1992	NULL
33	NULL
.	NULL

Pinto	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gattei	NULL
V	NULL
,	NULL
Aldinucci	NULL
D	NULL
,	NULL
Zagonel	NULL
V	NULL
,	NULL
Carbone	NULL
A	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
c-kit	NULL
receptor	NULL
in	NULL
human	NULL
lymphomas	NULL
is	NULL
restricted	NULL
to	NULL
Hodgkin	NULL
's	NULL
disease	NULL
and	NULL
CD30+*	NULL
anaplastic	NULL
large	NULL
cell	NULL
lymphomas	NULL
.	NULL

Blood	NULL
83:785	NULL
,	NULL
1994	NULL
34	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Cilia	NULL
AM	NULL
,	NULL
Bassi	NULL
P	NULL
,	NULL
Polito	NULL
P	NULL
,	NULL
Vaccher	NULL
E	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Tirelli	NULL
U	NULL
:	NULL
AIDS-related	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

CARBONE	NULL
ET	NULL
AL	NULL
Morphologic	NULL
and	NULL
immunophenotypic	NULL
study	NULL
of	NULL
biopsy	NULL
specimens	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
103:561	NULL
,	NULL
1995	NULL
35	NULL
.	NULL

Falini	NULL
B	NULL
,	NULL
Bigemna	NULL
B	NULL
,	NULL
Pasqualucci	NULL
L	NULL
,	NULL
Fizzotti	NULL
M	NULL
,	NULL
Martelli	NULL
MF	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Pinto	NULL
A	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Venturi	NULL
S	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Pescarmona	NULL
B	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Anagnastopoulos	NULL
I	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Flenghi	NULL
L	NULL
:	NULL
Distinctive	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Blood	NULL
87:465	NULL
,	NULL
1996	NULL
36	NULL
.	NULL

Gruss	NULL
H-J	NULL
,	NULL
Hirschstein	NULL
D	NULL
,	NULL
Wright	NULL
B	NULL
,	NULL
Ulrich	NULL
D	NULL
,	NULL
Caligiuri	NULL
MA	NULL
,	NULL
Barcos	NULL
M	NULL
,	NULL
Strockbine	NULL
L	NULL
,	NULL
Armitage	NULL
RJ	NULL
,	NULL
Dower	NULL
SK	NULL
:	NULL
Expression	NULL
and	NULL
function	NULL
of	NULL
CD40	NULL
on	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
and	NULL
the	NULL
possible	NULL
relevance	NULL
for	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Blood	NULL
84:2305	NULL
,	NULL
1994	NULL
37	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gruss	NULL
H-J	NULL
,	NULL
Pinto	NULL
A	NULL
:	NULL
CD40	NULL
ligand	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
T	NULL
cell	NULL
lymphomas	NULL
and	NULL
on	NULL
the	NULL
microenvironmental	NULL
reactive	NULL
T	NULL
cells	NULL
of	NULL
follicular	NULL
lymphomas	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
147:912	NULL
,	NULL
1995	NULL
38	NULL
.	NULL

Liebowitz	NULL
D	NULL
:	NULL
Epstein	NULL
Barr	NULL
virus	NULL
and	NULL
a	NULL
cellular	NULL
signaling	NULL
pathway	NULL
in	NULL
lymphomas	NULL
from	NULL
immunosuppressed	NULL
patients	NULL
N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
338:1413	NULL
,	NULL
1998	NULL
39	NULL
.	NULL

Larocca	NULL
LM	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Rinelli	NULL
A	NULL
,	NULL
Nori	NULL
S	NULL
,	NULL
Antinori	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Cingolani	NULL
A	NULL
,	NULL
Migliazza	NULL
A	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Camilleri-Broet	NULL
S	NULL
,	NULL
Raphael	NULL
M	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
:	NULL
The	NULL
molecular	NULL
and	NULL
phenotypic	NULL
profile	NULL
of	NULL
primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphoma	NULL
identifies	NULL
distinct	NULL
categories	NULL
of	NULL
the	NULL
disease	NULL
and	NULL
is	NULL
consistent	NULL
with	NULL
histogenetic	NULL
derivation	NULL
from	NULL
germinal	NULL
center-related	NULL
B	NULL
cells	NULL
.	NULL

Blood	NULL
92:1011	NULL
,	NULL
1998	NULL
40	NULL
.	NULL

Bessudo	NULL
A	NULL
,	NULL
Cherepakhin	NULL
V	NULL
,	NULL
Johnson	NULL
TA	NULL
,	NULL
Rassenti	NULL
LZ	NULL
,	NULL
Feigal	NULL
E	NULL
,	NULL
Kipps	NULL
TJ	NULL
:	NULL
Favored	NULL
use	NULL
of	NULL
immunoglobulin	NULL
V,4	NULL
genes	NULL
in	NULL
AIDS-associated	NULL
B-cell	NULL
lymphomas	NULL
.	NULL

Blood	NULL
88:252	NULL
,	NULL
1996	NULL
41	NULL
.	NULL

Gaidano	NULL
G	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Pastore	NULL
C	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Migliazza	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Roncella	NULL
S	NULL
,	NULL
Ferrarini	NULL
M	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Frequent	NULL
mutation	NULL
of	NULL
the	NULL
5°	NULL
noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Blood	NULL
89:3755	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1999	NULL
93	NULL
:	NULL
2319-2326	NULL
Human	NULL
Immunodeficiency	NULL
Virus-Associated	NULL
Hodgkin	NULL
's	NULL
Disease	NULL
Derives	NULL
From	NULL
Post-Germinal	NULL
Center	NULL
B	NULL
Cells	NULL
4	NULL
QM	NULL
“	NULL
Caw	NULL
,	NULL
.	NULL

A	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

®	NULL
``	NULL
Ctown®	NULL
@	NULL
``	NULL
20	NULL
Antonino	NULL
Carbone	NULL
,	NULL
Annunziata	NULL
Gloghini	NULL
,	NULL
Luigi	NULL
M.	NULL
Larocca	NULL
,	NULL
Andrea	NULL
Antinori	NULL
,	NULL
Brunangelo	NULL
Falini	NULL
,	NULL
Umberto	NULL
Tirelli	NULL
,	NULL
Riccardo	NULL
Dalla-Favera	NULL
and	NULL
Gianluca	NULL
Gaidano	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/93/7/2319.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Neoplasia	NULL
(	NULL
4182	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

